Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure
Identifieur interne : 000D16 ( Pmc/Corpus ); précédent : 000D15; suivant : 000D17Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure
Auteurs : Sung J. Yoo ; Taeyong Kwon ; Young S. LyooSource :
- Clinical and Experimental Vaccine Research [ 2287-3651 ] ; 2018.
Abstract
Influenza A viruses (IAVs) are genetically diverse and variable pathogens that share various hosts including human, swine, and domestic poultry. Interspecies and intercontinental viral spreads make the ecology of IAV more complex. Beside endemic IAV infections, human has been exposed to pandemic and zoonotic threats from avian and swine influenza viruses. Animal health also has been threatened by high pathogenic avian influenza viruses (in domestic poultry) and reverse zoonosis (in swine). Considering its dynamic interplay between species, prevention and control against IAV should be conducted effectively in both humans and animal sectors. Vaccination is one of the most efficient tools against IAV. Numerous vaccines against animal IAVs have been developed by a variety of vaccine technologies and some of them are currently commercially available. We summarize several challenges in control of IAVs faced by human and animals and discuss IAV vaccines for animal use with those application in susceptible populations.
Url:
DOI: 10.7774/cevr.2018.7.1.1
PubMed: 29399575
PubMed Central: 5795040
Links to Exploration step
PMC:5795040Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure</title><author><name sortKey="Yoo, Sung J" sort="Yoo, Sung J" uniqKey="Yoo S" first="Sung J." last="Yoo">Sung J. Yoo</name><affiliation><nlm:aff id="A1">College of Veterinary Medicine, Konkuk University, Seoul, Korea.</nlm:aff></affiliation></author><author><name sortKey="Kwon, Taeyong" sort="Kwon, Taeyong" uniqKey="Kwon T" first="Taeyong" last="Kwon">Taeyong Kwon</name><affiliation><nlm:aff id="A1">College of Veterinary Medicine, Konkuk University, Seoul, Korea.</nlm:aff></affiliation></author><author><name sortKey="Lyoo, Young S" sort="Lyoo, Young S" uniqKey="Lyoo Y" first="Young S." last="Lyoo">Young S. Lyoo</name><affiliation><nlm:aff id="A1">College of Veterinary Medicine, Konkuk University, Seoul, Korea.</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">29399575</idno><idno type="pmc">5795040</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795040</idno><idno type="RBID">PMC:5795040</idno><idno type="doi">10.7774/cevr.2018.7.1.1</idno><date when="2018">2018</date><idno type="wicri:Area/Pmc/Corpus">000D16</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000D16</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure</title><author><name sortKey="Yoo, Sung J" sort="Yoo, Sung J" uniqKey="Yoo S" first="Sung J." last="Yoo">Sung J. Yoo</name><affiliation><nlm:aff id="A1">College of Veterinary Medicine, Konkuk University, Seoul, Korea.</nlm:aff></affiliation></author><author><name sortKey="Kwon, Taeyong" sort="Kwon, Taeyong" uniqKey="Kwon T" first="Taeyong" last="Kwon">Taeyong Kwon</name><affiliation><nlm:aff id="A1">College of Veterinary Medicine, Konkuk University, Seoul, Korea.</nlm:aff></affiliation></author><author><name sortKey="Lyoo, Young S" sort="Lyoo, Young S" uniqKey="Lyoo Y" first="Young S." last="Lyoo">Young S. Lyoo</name><affiliation><nlm:aff id="A1">College of Veterinary Medicine, Konkuk University, Seoul, Korea.</nlm:aff></affiliation></author></analytic><series><title level="j">Clinical and Experimental Vaccine Research</title><idno type="ISSN">2287-3651</idno><idno type="eISSN">2287-366X</idno><imprint><date when="2018">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Influenza A viruses (IAVs) are genetically diverse and variable pathogens that share various hosts including human, swine, and domestic poultry. Interspecies and intercontinental viral spreads make the ecology of IAV more complex. Beside endemic IAV infections, human has been exposed to pandemic and zoonotic threats from avian and swine influenza viruses. Animal health also has been threatened by high pathogenic avian influenza viruses (in domestic poultry) and reverse zoonosis (in swine). Considering its dynamic interplay between species, prevention and control against IAV should be conducted effectively in both humans and animal sectors. Vaccination is one of the most efficient tools against IAV. Numerous vaccines against animal IAVs have been developed by a variety of vaccine technologies and some of them are currently commercially available. We summarize several challenges in control of IAVs faced by human and animals and discuss IAV vaccines for animal use with those application in susceptible populations.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author><author><name sortKey="Bean, Wj" uniqKey="Bean W">WJ Bean</name></author><author><name sortKey="Gorman, Ot" uniqKey="Gorman O">OT Gorman</name></author><author><name sortKey="Chambers, Tm" uniqKey="Chambers T">TM Chambers</name></author><author><name sortKey="Kawaoka, Y" uniqKey="Kawaoka Y">Y Kawaoka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author><author><name sortKey="Govorkova, Ea" uniqKey="Govorkova E">EA Govorkova</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cauldwell, Av" uniqKey="Cauldwell A">AV Cauldwell</name></author><author><name sortKey="Long, Js" uniqKey="Long J">JS Long</name></author><author><name sortKey="Moncorge, O" uniqKey="Moncorge O">O Moncorge</name></author><author><name sortKey="Barclay, Ws" uniqKey="Barclay W">WS Barclay</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Short, Kr" uniqKey="Short K">KR Short</name></author><author><name sortKey="Richard, M" uniqKey="Richard M">M Richard</name></author><author><name sortKey="Verhagen, Jh" uniqKey="Verhagen J">JH Verhagen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhou, L" uniqKey="Zhou L">L Zhou</name></author><author><name sortKey="Ren, R" uniqKey="Ren R">R Ren</name></author><author><name sortKey="Yang, L" uniqKey="Yang L">L Yang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Iuliano, Ad" uniqKey="Iuliano A">AD Iuliano</name></author><author><name sortKey="Jang, Y" uniqKey="Jang Y">Y Jang</name></author><author><name sortKey="Jones, J" uniqKey="Jones J">J Jones</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Smith, Gj" uniqKey="Smith G">GJ Smith</name></author><author><name sortKey="Vijaykrishna, D" uniqKey="Vijaykrishna D">D Vijaykrishna</name></author><author><name sortKey="Bahl, J" uniqKey="Bahl J">J Bahl</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Garten, Rj" uniqKey="Garten R">RJ Garten</name></author><author><name sortKey="Davis, Ct" uniqKey="Davis C">CT Davis</name></author><author><name sortKey="Russell, Ca" uniqKey="Russell C">CA Russell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vincent, A" uniqKey="Vincent A">A Vincent</name></author><author><name sortKey="Awada, L" uniqKey="Awada L">L Awada</name></author><author><name sortKey="Brown, I" uniqKey="Brown I">I Brown</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Peiris, M" uniqKey="Peiris M">M Peiris</name></author><author><name sortKey="Yen, Hl" uniqKey="Yen H">HL Yen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hayward, Ac" uniqKey="Hayward A">AC Hayward</name></author><author><name sortKey="Fragaszy, Eb" uniqKey="Fragaszy E">EB Fragaszy</name></author><author><name sortKey="Bermingham, A" uniqKey="Bermingham A">A Bermingham</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Horby, Pw" uniqKey="Horby P">PW Horby</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Shen, Yy" uniqKey="Shen Y">YY Shen</name></author><author><name sortKey="Ke, Cw" uniqKey="Ke C">CW Ke</name></author><author><name sortKey="Li, Q" uniqKey="Li Q">Q Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nguyen, Dc" uniqKey="Nguyen D">DC Nguyen</name></author><author><name sortKey="Uyeki, Tm" uniqKey="Uyeki T">TM Uyeki</name></author><author><name sortKey="Jadhao, S" uniqKey="Jadhao S">S Jadhao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee, Cw" uniqKey="Lee C">CW Lee</name></author><author><name sortKey="Senne, Da" uniqKey="Senne D">DA Senne</name></author><author><name sortKey="Linares, Ja" uniqKey="Linares J">JA Linares</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee, Dh" uniqKey="Lee D">DH Lee</name></author><author><name sortKey="Bertran, K" uniqKey="Bertran K">K Bertran</name></author><author><name sortKey="Kwon, Jh" uniqKey="Kwon J">JH Kwon</name></author><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee, Dh" uniqKey="Lee D">DH Lee</name></author><author><name sortKey="Torchetti, Mk" uniqKey="Torchetti M">MK Torchetti</name></author><author><name sortKey="Winker, K" uniqKey="Winker K">K Winker</name></author><author><name sortKey="Ip, Hs" uniqKey="Ip H">HS Ip</name></author><author><name sortKey="Song, Cs" uniqKey="Song C">CS Song</name></author><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Anderson, T" uniqKey="Anderson T">T Anderson</name></author><author><name sortKey="Capua, I" uniqKey="Capua I">I Capua</name></author><author><name sortKey="Dauphin, G" uniqKey="Dauphin G">G Dauphin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pfeiffer, Du" uniqKey="Pfeiffer D">DU Pfeiffer</name></author><author><name sortKey="Otte, Mj" uniqKey="Otte M">MJ Otte</name></author><author><name sortKey="Roland Holst, D" uniqKey="Roland Holst D">D Roland-Holst</name></author><author><name sortKey="Zilberman, D" uniqKey="Zilberman D">D Zilberman</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Molinari, Na" uniqKey="Molinari N">NA Molinari</name></author><author><name sortKey="Ortega Sanchez, Ir" uniqKey="Ortega Sanchez I">IR Ortega-Sanchez</name></author><author><name sortKey="Messonnier, Ml" uniqKey="Messonnier M">ML Messonnier</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Taubenberger, Jk" uniqKey="Taubenberger J">JK Taubenberger</name></author><author><name sortKey="Morens, Dm" uniqKey="Morens D">DM Morens</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Taubenberger, Jk" uniqKey="Taubenberger J">JK Taubenberger</name></author><author><name sortKey="Reid, Ah" uniqKey="Reid A">AH Reid</name></author><author><name sortKey="Lourens, Rm" uniqKey="Lourens R">RM Lourens</name></author><author><name sortKey="Wang, R" uniqKey="Wang R">R Wang</name></author><author><name sortKey="Jin, G" uniqKey="Jin G">G Jin</name></author><author><name sortKey="Fanning, Tg" uniqKey="Fanning T">TG Fanning</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Anhlan, D" uniqKey="Anhlan D">D Anhlan</name></author><author><name sortKey="Grundmann, N" uniqKey="Grundmann N">N Grundmann</name></author><author><name sortKey="Makalowski, W" uniqKey="Makalowski W">W Makalowski</name></author><author><name sortKey="Ludwig, S" uniqKey="Ludwig S">S Ludwig</name></author><author><name sortKey="Scholtissek, C" uniqKey="Scholtissek C">C Scholtissek</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Reid, Ah" uniqKey="Reid A">AH Reid</name></author><author><name sortKey="Fanning, Tg" uniqKey="Fanning T">TG Fanning</name></author><author><name sortKey="Janczewski, Ta" uniqKey="Janczewski T">TA Janczewski</name></author><author><name sortKey="Lourens, Rm" uniqKey="Lourens R">RM Lourens</name></author><author><name sortKey="Taubenberger, Jk" uniqKey="Taubenberger J">JK Taubenberger</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gibbs, Mj" uniqKey="Gibbs M">MJ Gibbs</name></author><author><name sortKey="Gibbs, Aj" uniqKey="Gibbs A">AJ Gibbs</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fanning, Tg" uniqKey="Fanning T">TG Fanning</name></author><author><name sortKey="Slemons, Rd" uniqKey="Slemons R">RD Slemons</name></author><author><name sortKey="Reid, Ah" uniqKey="Reid A">AH Reid</name></author><author><name sortKey="Janczewski, Ta" uniqKey="Janczewski T">TA Janczewski</name></author><author><name sortKey="Dean, J" uniqKey="Dean J">J Dean</name></author><author><name sortKey="Taubenberger, Jk" uniqKey="Taubenberger J">JK Taubenberger</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Taubenberger, Jk" uniqKey="Taubenberger J">JK Taubenberger</name></author><author><name sortKey="Kash, Jc" uniqKey="Kash J">JC Kash</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gu, M" uniqKey="Gu M">M Gu</name></author><author><name sortKey="Xu, L" uniqKey="Xu L">L Xu</name></author><author><name sortKey="Wang, X" uniqKey="Wang X">X Wang</name></author><author><name sortKey="Liu, X" uniqKey="Liu X">X Liu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Epperson, S" uniqKey="Epperson S">S Epperson</name></author><author><name sortKey="Jhung, M" uniqKey="Jhung M">M Jhung</name></author><author><name sortKey="Richards, S" uniqKey="Richards S">S Richards</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bowman, As" uniqKey="Bowman A">AS Bowman</name></author><author><name sortKey="Walia, Rr" uniqKey="Walia R">RR Walia</name></author><author><name sortKey="Nolting, Jm" uniqKey="Nolting J">JM Nolting</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Krauss, S" uniqKey="Krauss S">S Krauss</name></author><author><name sortKey="Stallknecht, De" uniqKey="Stallknecht D">DE Stallknecht</name></author><author><name sortKey="Slemons, Rd" uniqKey="Slemons R">RD Slemons</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ellis, Tm" uniqKey="Ellis T">TM Ellis</name></author><author><name sortKey="Bousfield, Rb" uniqKey="Bousfield R">RB Bousfield</name></author><author><name sortKey="Bissett, La" uniqKey="Bissett L">LA Bissett</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Desvaux, S" uniqKey="Desvaux S">S Desvaux</name></author><author><name sortKey="Marx, N" uniqKey="Marx N">N Marx</name></author><author><name sortKey="Ong, S" uniqKey="Ong S">S Ong</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Harfoot, R" uniqKey="Harfoot R">R Harfoot</name></author><author><name sortKey="Webby, Rj" uniqKey="Webby R">RJ Webby</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Rushton, J" uniqKey="Rushton J">J Rushton</name></author><author><name sortKey="Gilbert, W" uniqKey="Gilbert W">W Gilbert</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author><author><name sortKey="Hill, Re" uniqKey="Hill R">RE Hill</name></author><author><name sortKey="Clifford, J" uniqKey="Clifford J">J Clifford</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zimmerman, Jj" uniqKey="Zimmerman J">JJ Zimmerman</name></author><author><name sortKey="Karriker, La" uniqKey="Karriker L">LA Karriker</name></author><author><name sortKey="Ramirez, A" uniqKey="Ramirez A">A Ramirez</name></author><author><name sortKey="Schwartz, Kj" uniqKey="Schwartz K">KJ Schwartz</name></author><author><name sortKey="Stevenson, Gw" uniqKey="Stevenson G">GW Stevenson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Smith, Rd" uniqKey="Smith R">RD Smith</name></author><author><name sortKey="Keogh Brown, Mr" uniqKey="Keogh Brown M">MR Keogh-Brown</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ito, T" uniqKey="Ito T">T Ito</name></author><author><name sortKey="Couceiro, Jn" uniqKey="Couceiro J">JN Couceiro</name></author><author><name sortKey="Kelm, S" uniqKey="Kelm S">S Kelm</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Trebbien, R" uniqKey="Trebbien R">R Trebbien</name></author><author><name sortKey="Larsen, Le" uniqKey="Larsen L">LE Larsen</name></author><author><name sortKey="Viuff, Bm" uniqKey="Viuff B">BM Viuff</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chan, Rw" uniqKey="Chan R">RW Chan</name></author><author><name sortKey="Karamanska, R" uniqKey="Karamanska R">R Karamanska</name></author><author><name sortKey="Van Poucke, S" uniqKey="Van Poucke S">S Van Poucke</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dawood, Fs" uniqKey="Dawood F">FS Dawood</name></author><author><name sortKey="Jain, S" uniqKey="Jain S">S Jain</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rajao, Ds" uniqKey="Rajao D">DS Rajao</name></author><author><name sortKey="Walia, Rr" uniqKey="Walia R">RR Walia</name></author><author><name sortKey="Campbell, B" uniqKey="Campbell B">B Campbell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nelson, Mi" uniqKey="Nelson M">MI Nelson</name></author><author><name sortKey="Gramer, Mr" uniqKey="Gramer M">MR Gramer</name></author><author><name sortKey="Vincent, Al" uniqKey="Vincent A">AL Vincent</name></author><author><name sortKey="Holmes, Ec" uniqKey="Holmes E">EC Holmes</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shortridge, Kf" uniqKey="Shortridge K">KF Shortridge</name></author><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author><author><name sortKey="Butterfield, Wk" uniqKey="Butterfield W">WK Butterfield</name></author><author><name sortKey="Campbell, Ch" uniqKey="Campbell C">CH Campbell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gilbert, M" uniqKey="Gilbert M">M Gilbert</name></author><author><name sortKey="Conchedda, G" uniqKey="Conchedda G">G Conchedda</name></author><author><name sortKey="Van Boeckel, Tp" uniqKey="Van Boeckel T">TP Van Boeckel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author><author><name sortKey="Kapczynski, Dr" uniqKey="Kapczynski D">DR Kapczynski</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vincent, Al" uniqKey="Vincent A">AL Vincent</name></author><author><name sortKey="Perez, Dr" uniqKey="Perez D">DR Perez</name></author><author><name sortKey="Rajao, D" uniqKey="Rajao D">D Rajao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Peiris, Js" uniqKey="Peiris J">JS Peiris</name></author><author><name sortKey="Cowling, Bj" uniqKey="Cowling B">BJ Cowling</name></author><author><name sortKey="Wu, Jt" uniqKey="Wu J">JT Wu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bowman, As" uniqKey="Bowman A">AS Bowman</name></author><author><name sortKey="Nolting, Jm" uniqKey="Nolting J">JM Nolting</name></author><author><name sortKey="Nelson, Sw" uniqKey="Nelson S">SW Nelson</name></author><author><name sortKey="Slemons, Rd" uniqKey="Slemons R">RD Slemons</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author><author><name sortKey="Pavade, G" uniqKey="Pavade G">G Pavade</name></author><author><name sortKey="Hamilton, K" uniqKey="Hamilton K">K Hamilton</name></author><author><name sortKey="Vallat, B" uniqKey="Vallat B">B Vallat</name></author><author><name sortKey="Miyagishima, K" uniqKey="Miyagishima K">K Miyagishima</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee, Dh" uniqKey="Lee D">DH Lee</name></author><author><name sortKey="Song, Cs" uniqKey="Song C">CS Song</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Perk, S" uniqKey="Perk S">S Perk</name></author><author><name sortKey="Golender, N" uniqKey="Golender N">N Golender</name></author><author><name sortKey="Banet Noach, C" uniqKey="Banet Noach C">C Banet-Noach</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Naeem, K" uniqKey="Naeem K">K Naeem</name></author><author><name sortKey="Siddique, N" uniqKey="Siddique N">N Siddique</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lewis, Ns" uniqKey="Lewis N">NS Lewis</name></author><author><name sortKey="Russell, Ca" uniqKey="Russell C">CA Russell</name></author><author><name sortKey="Langat, P" uniqKey="Langat P">P Langat</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kong, W" uniqKey="Kong W">W Kong</name></author><author><name sortKey="Ye, J" uniqKey="Ye J">J Ye</name></author><author><name sortKey="Guan, S" uniqKey="Guan S">S Guan</name></author><author><name sortKey="Liu, J" uniqKey="Liu J">J Liu</name></author><author><name sortKey="Pu, J" uniqKey="Pu J">J Pu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vincent, Al" uniqKey="Vincent A">AL Vincent</name></author><author><name sortKey="Ma, W" uniqKey="Ma W">W Ma</name></author><author><name sortKey="Lager, Km" uniqKey="Lager K">KM Lager</name></author><author><name sortKey="Janke, Bh" uniqKey="Janke B">BH Janke</name></author><author><name sortKey="Richt, Ja" uniqKey="Richt J">JA Richt</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rashid, A" uniqKey="Rashid A">A Rashid</name></author><author><name sortKey="Rasheed, K" uniqKey="Rasheed K">K Rasheed</name></author><author><name sortKey="Akhtar, M" uniqKey="Akhtar M">M Akhtar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rahn, J" uniqKey="Rahn J">J Rahn</name></author><author><name sortKey="Hoffmann, D" uniqKey="Hoffmann D">D Hoffmann</name></author><author><name sortKey="Harder, Tc" uniqKey="Harder T">TC Harder</name></author><author><name sortKey="Beer, M" uniqKey="Beer M">M Beer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Spackman, E" uniqKey="Spackman E">E Spackman</name></author><author><name sortKey="Pantin Jackwood, Mj" uniqKey="Pantin Jackwood M">MJ Pantin-Jackwood</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Trombetta, Cm" uniqKey="Trombetta C">CM Trombetta</name></author><author><name sortKey="Perini, D" uniqKey="Perini D">D Perini</name></author><author><name sortKey="Mather, S" uniqKey="Mather S">S Mather</name></author><author><name sortKey="Temperton, N" uniqKey="Temperton N">N Temperton</name></author><author><name sortKey="Montomoli, E" uniqKey="Montomoli E">E Montomoli</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Park, Aw" uniqKey="Park A">AW Park</name></author><author><name sortKey="Daly, Jm" uniqKey="Daly J">JM Daly</name></author><author><name sortKey="Lewis, Ns" uniqKey="Lewis N">NS Lewis</name></author><author><name sortKey="Smith, Dj" uniqKey="Smith D">DJ Smith</name></author><author><name sortKey="Wood, Jl" uniqKey="Wood J">JL Wood</name></author><author><name sortKey="Grenfell, Bt" uniqKey="Grenfell B">BT Grenfell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Abdelwhab, Em" uniqKey="Abdelwhab E">EM Abdelwhab</name></author><author><name sortKey="Hassan, Mk" uniqKey="Hassan M">MK Hassan</name></author><author><name sortKey="Abdel Moneim, As" uniqKey="Abdel Moneim A">AS Abdel-Moneim</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee, Dh" uniqKey="Lee D">DH Lee</name></author><author><name sortKey="Fusaro, A" uniqKey="Fusaro A">A Fusaro</name></author><author><name sortKey="Song, Cs" uniqKey="Song C">CS Song</name></author><author><name sortKey="Suarez, Dl" uniqKey="Suarez D">DL Suarez</name></author><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee, Cw" uniqKey="Lee C">CW Lee</name></author><author><name sortKey="Senne, Da" uniqKey="Senne D">DA Senne</name></author><author><name sortKey="Suarez, Dl" uniqKey="Suarez D">DL Suarez</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vijaykrishna, D" uniqKey="Vijaykrishna D">D Vijaykrishna</name></author><author><name sortKey="Smith, Gj" uniqKey="Smith G">GJ Smith</name></author><author><name sortKey="Pybus, Og" uniqKey="Pybus O">OG Pybus</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Harder, Tc" uniqKey="Harder T">TC Harder</name></author><author><name sortKey="Grosse Beilage, E" uniqKey="Grosse Beilage E">E Grosse Beilage</name></author><author><name sortKey="Lange, E" uniqKey="Lange E">E Lange</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cecchinato, M" uniqKey="Cecchinato M">M Cecchinato</name></author><author><name sortKey="Catelli, E" uniqKey="Catelli E">E Catelli</name></author><author><name sortKey="Lupini, C" uniqKey="Lupini C">C Lupini</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Franzo, G" uniqKey="Franzo G">G Franzo</name></author><author><name sortKey="Tucciarone, Cm" uniqKey="Tucciarone C">CM Tucciarone</name></author><author><name sortKey="Cecchinato, M" uniqKey="Cecchinato M">M Cecchinato</name></author><author><name sortKey="Drigo, M" uniqKey="Drigo M">M Drigo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kwon, T" uniqKey="Kwon T">T Kwon</name></author><author><name sortKey="Lee, Du" uniqKey="Lee D">DU Lee</name></author><author><name sortKey="Yoo, Sj" uniqKey="Yoo S">SJ Yoo</name></author><author><name sortKey="Je, Sh" uniqKey="Je S">SH Je</name></author><author><name sortKey="Shin, Jy" uniqKey="Shin J">JY Shin</name></author><author><name sortKey="Lyoo, Ys" uniqKey="Lyoo Y">YS Lyoo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoo, Sj" uniqKey="Yoo S">SJ Yoo</name></author><author><name sortKey="Kwon, T" uniqKey="Kwon T">T Kwon</name></author><author><name sortKey="Kang, K" uniqKey="Kang K">K Kang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rodpothong, P" uniqKey="Rodpothong P">P Rodpothong</name></author><author><name sortKey="Auewarakul, P" uniqKey="Auewarakul P">P Auewarakul</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rajao, Ds" uniqKey="Rajao D">DS Rajao</name></author><author><name sortKey="Loving, Cl" uniqKey="Loving C">CL Loving</name></author><author><name sortKey="Gauger, Pc" uniqKey="Gauger P">PC Gauger</name></author><author><name sortKey="Kitikoon, P" uniqKey="Kitikoon P">P Kitikoon</name></author><author><name sortKey="Vincent, Al" uniqKey="Vincent A">AL Vincent</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gauger, Pc" uniqKey="Gauger P">PC Gauger</name></author><author><name sortKey="Vincent, Al" uniqKey="Vincent A">AL Vincent</name></author><author><name sortKey="Loving, Cl" uniqKey="Loving C">CL Loving</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vincent, Al" uniqKey="Vincent A">AL Vincent</name></author><author><name sortKey="Lager, Km" uniqKey="Lager K">KM Lager</name></author><author><name sortKey="Janke, Bh" uniqKey="Janke B">BH Janke</name></author><author><name sortKey="Gramer, Mr" uniqKey="Gramer M">MR Gramer</name></author><author><name sortKey="Richt, Ja" uniqKey="Richt J">JA Richt</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Khurana, S" uniqKey="Khurana S">S Khurana</name></author><author><name sortKey="Loving, Cl" uniqKey="Loving C">CL Loving</name></author><author><name sortKey="Manischewitz, J" uniqKey="Manischewitz J">J Manischewitz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sun, S" uniqKey="Sun S">S Sun</name></author><author><name sortKey="Cui, Z" uniqKey="Cui Z">Z Cui</name></author><author><name sortKey="Wang, J" uniqKey="Wang J">J Wang</name></author><author><name sortKey="Wang, Z" uniqKey="Wang Z">Z Wang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rajao, Ds" uniqKey="Rajao D">DS Rajao</name></author><author><name sortKey="Sandbulte, Mr" uniqKey="Sandbulte M">MR Sandbulte</name></author><author><name sortKey="Gauger, Pc" uniqKey="Gauger P">PC Gauger</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Dutta, A" uniqKey="Dutta A">A Dutta</name></author><author><name sortKey="Huang, Ct" uniqKey="Huang C">CT Huang</name></author><author><name sortKey="Lin, Cy" uniqKey="Lin C">CY Lin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Savill, Nj" uniqKey="Savill N">NJ Savill</name></author><author><name sortKey="St Rose, Sg" uniqKey="St Rose S">SG St Rose</name></author><author><name sortKey="Keeling, Mj" uniqKey="Keeling M">MJ Keeling</name></author><author><name sortKey="Woolhouse, Me" uniqKey="Woolhouse M">ME Woolhouse</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Poetri, On" uniqKey="Poetri O">ON Poetri</name></author><author><name sortKey="Van Boven, M" uniqKey="Van Boven M">M Van Boven</name></author><author><name sortKey="Claassen, I" uniqKey="Claassen I">I Claassen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wright, Pf" uniqKey="Wright P">PF Wright</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhou, F" uniqKey="Zhou F">F Zhou</name></author><author><name sortKey="Zhou, J" uniqKey="Zhou J">J Zhou</name></author><author><name sortKey="Ma, L" uniqKey="Ma L">L Ma</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hu, Ay" uniqKey="Hu A">AY Hu</name></author><author><name sortKey="Tseng, Yf" uniqKey="Tseng Y">YF Tseng</name></author><author><name sortKey="Weng, Tc" uniqKey="Weng T">TC Weng</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ping, J" uniqKey="Ping J">J Ping</name></author><author><name sortKey="Lopes, Tj" uniqKey="Lopes T">TJ Lopes</name></author><author><name sortKey="Nidom, Ca" uniqKey="Nidom C">CA Nidom</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Smith, Jh" uniqKey="Smith J">JH Smith</name></author><author><name sortKey="Papania, M" uniqKey="Papania M">M Papania</name></author><author><name sortKey="Knaus, D" uniqKey="Knaus D">D Knaus</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liu, Q" uniqKey="Liu Q">Q Liu</name></author><author><name sortKey="Mena, I" uniqKey="Mena I">I Mena</name></author><author><name sortKey="Ma, J" uniqKey="Ma J">J Ma</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ma, J" uniqKey="Ma J">J Ma</name></author><author><name sortKey="Lee, J" uniqKey="Lee J">J Lee</name></author><author><name sortKey="Liu, H" uniqKey="Liu H">H Liu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hu, Z" uniqKey="Hu Z">Z Hu</name></author><author><name sortKey="Liu, X" uniqKey="Liu X">X Liu</name></author><author><name sortKey="Jiao, X" uniqKey="Jiao X">X Jiao</name></author><author><name sortKey="Liu, X" uniqKey="Liu X">X Liu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nakaya, T" uniqKey="Nakaya T">T Nakaya</name></author><author><name sortKey="Cros, J" uniqKey="Cros J">J Cros</name></author><author><name sortKey="Park, Ms" uniqKey="Park M">MS Park</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ma, W" uniqKey="Ma W">W Ma</name></author><author><name sortKey="Richt, Ja" uniqKey="Richt J">JA Richt</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Suarez, Dl" uniqKey="Suarez D">DL Suarez</name></author><author><name sortKey="Pantin Jackwood, Mj" uniqKey="Pantin Jackwood M">MJ Pantin-Jackwood</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tsunekuni, R" uniqKey="Tsunekuni R">R Tsunekuni</name></author><author><name sortKey="Hikono, H" uniqKey="Hikono H">H Hikono</name></author><author><name sortKey="Tanikawa, T" uniqKey="Tanikawa T">T Tanikawa</name></author><author><name sortKey="Kurata, R" uniqKey="Kurata R">R Kurata</name></author><author><name sortKey="Nakaya, T" uniqKey="Nakaya T">T Nakaya</name></author><author><name sortKey="Saito, T" uniqKey="Saito T">T Saito</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoshida, A" uniqKey="Yoshida A">A Yoshida</name></author><author><name sortKey="Samal, Sk" uniqKey="Samal S">SK Samal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bublot, M" uniqKey="Bublot M">M Bublot</name></author><author><name sortKey="Pritchard, N" uniqKey="Pritchard N">N Pritchard</name></author><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Richard Mazet, A" uniqKey="Richard Mazet A">A Richard-Mazet</name></author><author><name sortKey="Goutebroze, S" uniqKey="Goutebroze S">S Goutebroze</name></author><author><name sortKey="Le Gros, Fx" uniqKey="Le Gros F">FX Le Gros</name></author><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author><author><name sortKey="Bublot, M" uniqKey="Bublot M">M Bublot</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Iavarone, C" uniqKey="Iavarone C">C Iavarone</name></author><author><name sortKey="O Hagan, Dt" uniqKey="O Hagan D">DT O'Hagan</name></author><author><name sortKey="Yu, D" uniqKey="Yu D">D Yu</name></author><author><name sortKey="Delahaye, Nf" uniqKey="Delahaye N">NF Delahaye</name></author><author><name sortKey="Ulmer, Jb" uniqKey="Ulmer J">JB Ulmer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Diken, M" uniqKey="Diken M">M Diken</name></author><author><name sortKey="Kreiter, S" uniqKey="Kreiter S">S Kreiter</name></author><author><name sortKey="Selmi, A" uniqKey="Selmi A">A Selmi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Barbalat, R" uniqKey="Barbalat R">R Barbalat</name></author><author><name sortKey="Ewald, Se" uniqKey="Ewald S">SE Ewald</name></author><author><name sortKey="Mouchess, Ml" uniqKey="Mouchess M">ML Mouchess</name></author><author><name sortKey="Barton, Gm" uniqKey="Barton G">GM Barton</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moon, Sl" uniqKey="Moon S">SL Moon</name></author><author><name sortKey="Wilusz, J" uniqKey="Wilusz J">J Wilusz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kariko, K" uniqKey="Kariko K">K Kariko</name></author><author><name sortKey="Muramatsu, H" uniqKey="Muramatsu H">H Muramatsu</name></author><author><name sortKey="Ludwig, J" uniqKey="Ludwig J">J Ludwig</name></author><author><name sortKey="Weissman, D" uniqKey="Weissman D">D Weissman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jones, Kl" uniqKey="Jones K">KL Jones</name></author><author><name sortKey="Drane, D" uniqKey="Drane D">D Drane</name></author><author><name sortKey="Gowans, Ej" uniqKey="Gowans E">EJ Gowans</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hoerr, I" uniqKey="Hoerr I">I Hoerr</name></author><author><name sortKey="Obst, R" uniqKey="Obst R">R Obst</name></author><author><name sortKey="Rammensee, Hg" uniqKey="Rammensee H">HG Rammensee</name></author><author><name sortKey="Jung, G" uniqKey="Jung G">G Jung</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Paul, S" uniqKey="Paul S">S Paul</name></author><author><name sortKey="Stang, A" uniqKey="Stang A">A Stang</name></author><author><name sortKey="Lennartz, K" uniqKey="Lennartz K">K Lennartz</name></author><author><name sortKey="Tenbusch, M" uniqKey="Tenbusch M">M Tenbusch</name></author><author><name sortKey="Uberla, K" uniqKey="Uberla K">K Uberla</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Petsch, B" uniqKey="Petsch B">B Petsch</name></author><author><name sortKey="Schnee, M" uniqKey="Schnee M">M Schnee</name></author><author><name sortKey="Vogel, Ab" uniqKey="Vogel A">AB Vogel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bahl, K" uniqKey="Bahl K">K Bahl</name></author><author><name sortKey="Senn, Jj" uniqKey="Senn J">JJ Senn</name></author><author><name sortKey="Yuzhakov, O" uniqKey="Yuzhakov O">O Yuzhakov</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ekiert, Dc" uniqKey="Ekiert D">DC Ekiert</name></author><author><name sortKey="Friesen, Rh" uniqKey="Friesen R">RH Friesen</name></author><author><name sortKey="Bhabha, G" uniqKey="Bhabha G">G Bhabha</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wiersma, Lc" uniqKey="Wiersma L">LC Wiersma</name></author><author><name sortKey="Rimmelzwaan, Gf" uniqKey="Rimmelzwaan G">GF Rimmelzwaan</name></author><author><name sortKey="De Vries, Rd" uniqKey="De Vries R">RD de Vries</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nayak, B" uniqKey="Nayak B">B Nayak</name></author><author><name sortKey="Kumar, S" uniqKey="Kumar S">S Kumar</name></author><author><name sortKey="Dinapoli, Jm" uniqKey="Dinapoli J">JM DiNapoli</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wong, Ss" uniqKey="Wong S">SS Wong</name></author><author><name sortKey="Webby, Rj" uniqKey="Webby R">RJ Webby</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Heinen, Pp" uniqKey="Heinen P">PP Heinen</name></author><author><name sortKey="Rijsewijk, Fa" uniqKey="Rijsewijk F">FA Rijsewijk</name></author><author><name sortKey="De Boer Luijtze, Ea" uniqKey="De Boer Luijtze E">EA de Boer-Luijtze</name></author><author><name sortKey="Bianchi, At" uniqKey="Bianchi A">AT Bianchi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tumpey, Tm" uniqKey="Tumpey T">TM Tumpey</name></author><author><name sortKey="Alvarez, R" uniqKey="Alvarez R">R Alvarez</name></author><author><name sortKey="Swayne, De" uniqKey="Swayne D">DE Swayne</name></author><author><name sortKey="Suarez, Dl" uniqKey="Suarez D">DL Suarez</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Brahmakshatriya, Vr" uniqKey="Brahmakshatriya V">VR Brahmakshatriya</name></author><author><name sortKey="Lupiani, B" uniqKey="Lupiani B">B Lupiani</name></author><author><name sortKey="Reddy, Sm" uniqKey="Reddy S">SM Reddy</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rohrs, S" uniqKey="Rohrs S">S Rohrs</name></author><author><name sortKey="Kalthoff, D" uniqKey="Kalthoff D">D Kalthoff</name></author><author><name sortKey="Beer, M" uniqKey="Beer M">M Beer</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Exp Vaccine Res</journal-id><journal-id journal-id-type="iso-abbrev">Clin Exp Vaccine Res</journal-id><journal-id journal-id-type="publisher-id">CEVR</journal-id><journal-title-group><journal-title>Clinical and Experimental Vaccine Research</journal-title></journal-title-group><issn pub-type="ppub">2287-3651</issn><issn pub-type="epub">2287-366X</issn><publisher><publisher-name>The Korean Vaccine Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29399575</article-id><article-id pub-id-type="pmc">5795040</article-id><article-id pub-id-type="doi">10.7774/cevr.2018.7.1.1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0892-2718</contrib-id><name><surname>Yoo</surname><given-names>Sung J.</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9026-4365</contrib-id><name><surname>Kwon</surname><given-names>Taeyong</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0048-1911</contrib-id><name><surname>Lyoo</surname><given-names>Young S.</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib></contrib-group><aff id="A1">College of Veterinary Medicine, Konkuk University, Seoul, Korea.</aff><author-notes><corresp>Corresponding author: Young S. Lyoo. College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea. Tel: +82-2-450-3719, Fax: +82-2-6008-3791, <email>lyoo@konkuk.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>29</day><month>1</month><year>2018</year></pub-date><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>15</lpage><history><date date-type="received"><day>18</day><month>11</month><year>2017</year></date><date date-type="rev-recd"><day>07</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>© Korean Vaccine Society.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Korean Vaccine Society</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Influenza A viruses (IAVs) are genetically diverse and variable pathogens that share various hosts including human, swine, and domestic poultry. Interspecies and intercontinental viral spreads make the ecology of IAV more complex. Beside endemic IAV infections, human has been exposed to pandemic and zoonotic threats from avian and swine influenza viruses. Animal health also has been threatened by high pathogenic avian influenza viruses (in domestic poultry) and reverse zoonosis (in swine). Considering its dynamic interplay between species, prevention and control against IAV should be conducted effectively in both humans and animal sectors. Vaccination is one of the most efficient tools against IAV. Numerous vaccines against animal IAVs have been developed by a variety of vaccine technologies and some of them are currently commercially available. We summarize several challenges in control of IAVs faced by human and animals and discuss IAV vaccines for animal use with those application in susceptible populations.</p></abstract><kwd-group><kwd>Influenza A virus</kwd><kwd>Human</kwd><kwd>Poultry</kwd><kwd>Swine</kwd><kwd>Endemic diseases</kwd><kwd>Pandemics</kwd><kwd>Zoonoses</kwd><kwd>Vaccines</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Konkuk University</institution><institution-id institution-id-type="CrossRef">http://dx.doi.org/10.13039/501100002641</institution-id></institution-wrap></funding-source></award-group></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Influenza A viruses (IAVs) are among the most unpredictable pathogen that threatens human and animal health by continuous evolution through antigenic drift and shift. While the natural reservoirs of IAVs have been known as aquatic wild birds (order <italic>Anseriformes</italic> or <italic>Charadriiformes</italic>), the viruses can spill over to susceptible host such as terrestrial birds and mammals including humans [<xref rid="B1" ref-type="bibr">1</xref><xref rid="B2" ref-type="bibr">2</xref>]. Through complex interactions between viral, host, and environmental factors that determine susceptibility and transmissibility of IAV [<xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref>], the cross-species infection can be either transient or endemic or epidemic or even occasionally pandemic [<xref rid="B5" ref-type="bibr">5</xref><xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">8</xref><xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref>].</p><p>Multiple spill-over events and viral adaptation process have resulted in the establishment of stable lineages of IAVs per susceptible host: human (H1N1, H1N2, H2N2, and H3N2), swine (H1N1, H1N2, and H3N2), equine (H3N8 and H7N7), and domestic poultry (many subtypes, H9N2, H6N1, and etc.). Most endemic IAV infections are clinically asymptomatic or cause mild respiratory signs; those endemic strains have been known as seasonal flu viruses in human [<xref rid="B11" ref-type="bibr">11</xref><xref rid="B12" ref-type="bibr">12</xref>] and as low-pathogenic avian influenza viruses (LPAIVs) in poultry [<xref rid="B13" ref-type="bibr">13</xref>]. However, continuous emergence of novel IAV reassortants from non-human hosts such as pigs and poultry, which is possibly susceptible to human population but have not been exposed before poses a potential pandemic threat to public health [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B14" ref-type="bibr">14</xref>]. Furthermore, in domestic poultry, highly-pathogenic avian influenza virus (HPAIV) can arise from H5 and H7 LPAIV via acquisition of multibasic amino acid cleavage sites of hemagglutinin (HA) molecule [<xref rid="B15" ref-type="bibr">15</xref><xref rid="B16" ref-type="bibr">16</xref>] and intercontinental spreads by migratory birds have made HPAIV as a global panzootic disease [<xref rid="B17" ref-type="bibr">17</xref><xref rid="B18" ref-type="bibr">18</xref>].</p><p>Considering the substantial threats of IAVs to human and animal health, the viruses are monitored and controlled through a global collaboration of world organizations such as World Organisation for Animal Health (OIE), Food and Agriculture Organization of the United Nations (FAO), and World Health Organization in the concept of “One Health” [<xref rid="B4" ref-type="bibr">4</xref><xref rid="B19" ref-type="bibr">19</xref><xref rid="B20" ref-type="bibr">20</xref>]. OFFLU, the OIE/FAO network of expertise on animal influenza, was developed and the vision of the consortium is as follows. The animal health community will provide early recognition and characterization of emerging influenza viral strains in animal populations, and effective management of known infections, thereby better managing the risk to human health and promoting global food security, animal health and welfare, and other community benefits derived from domestic animals and wildlife.</p><p>Vaccination is considered the most effective tool for the control and prevention of IAV infections in both humans and animals. However, especially for livestock animals in industrial settings (e.g., rapid turnover and high-density stocking), careful applications of IAV vaccines are required with a high level of biosecurity control and periodic surveillance for the vaccines not to work as driving forces that accelerate the viral evolution. While inactivated vaccines have been used conventionally worldwide in human and animal medicine, new generation IAV vaccines adopting recent technologies have been being developed and commercialized. Here, we review challenges of influenza virus that humans and animals face today highlighting specific concerns for each host species (human, domestic poultry, and swine) and discuss influenza vaccines in their usages, application strategies, and developments.</p></sec><sec><title>Seasonal, Pandemic, and Zoonotic Influenza Viruses in Humans</title><p>Influenza infection in humans can be classified into seasonal, pandemic, and zoonotic form. Seasonal flu is caused by influenza A, B, and C viruses and accounts for about 3 to 5 million cases of severe illness, and about 250,000 to 500,000 of deaths annually worldwide [<xref rid="B21" ref-type="bibr">21</xref>]. It has been estimated that the total annual economic burdens of seasonal influenza epidemics amounted to $87.1 billion [<xref rid="B22" ref-type="bibr">22</xref>]. Of three types of influenza, type A is known most virulent. Genetic subtypes of currently circulating seasonal IAV strains are H1N1 and H3N2 [<xref rid="B23" ref-type="bibr">23</xref>] and the epidemics have been dominated by H3N2 since 1968 when the “Hong Kong flu” occurred [<xref rid="B24" ref-type="bibr">24</xref>].</p><p>Influenza pandemic occurs when people are immunologically naïve to a newly emerged IAV and the virus exhibits sustainable transmissibility between humans. A total of four influenza pandemics have occurred since the 20th century: Spanish flu pandemic (H1N1, 1918–1920), Asian flu pandemic (H2N2, 1957–1958), Hong Kong flu pandemic (H3N2, 1968–1969), and swine flu pandemic (H1N1pdm09, 2009–2010). The Spanish flu is among the most devastating pandemic, having killed at least 50 million people. Subsequent pandemics have resulted in many fewer fatalities: the Asian flu (1.5 million), the Hong Kong flu (1 million), the swine flu (>18,500) [<xref rid="B2" ref-type="bibr">2</xref>]. The causative viral strain for each epidemic has been emerged from genomic reassorment within avian host (Asian flu and Hong Kong flu) or porcine host (swine flu). In case of Spanish flu, it is still controversial whether the virus had been a reassortant generated in mammals or a directly adapted avian influenza that crossed the species barrier from birds to human [<xref rid="B25" ref-type="bibr">25</xref><xref rid="B26" ref-type="bibr">26</xref><xref rid="B27" ref-type="bibr">27</xref><xref rid="B28" ref-type="bibr">28</xref><xref rid="B29" ref-type="bibr">29</xref>]. The several descendants of pandemic influenza virus strains have established a novel lineage in humans and become a regularly circulating seasonal flu virus (e.g., H1N1, H3N2, and H1N1pdm09) [<xref rid="B30" ref-type="bibr">30</xref>].</p><p>Zoonotic influenza viruses are similar to pandemic influenza viruses in the immune status of human populations against the newly emerged viruses, except that the infections by those viruses end as sporadic individual events with very limited transmission to others. Although avian or pig influenza viruses do not infect humans in general, sporadic human infection can be made via direct contact with infected animals or contaminated environments. Until now, human infections by avian influenza (H5N1, H5N6, H7N7, H7N9, H9N2, and H10N8) [<xref rid="B31" ref-type="bibr">31</xref>] and swine influenza (variant H1N1, H1N2, and H3N2) have been reported [<xref rid="B32" ref-type="bibr">32</xref><xref rid="B33" ref-type="bibr">33</xref>]. The disease severity in human varies according to viral strain; high lethality has been recorded in H7N9 (612 deaths among 1,565 infected patients since 2008), H5N1 (454 deaths among 860 infected patients since 2003), and H5N6 (7 deaths among 17 infected patients since 2016) [<xref rid="B34" ref-type="bibr">34</xref>]. H5N1 cases have been reported in 16 different countries distributed across Southeast Asia to Eastern Europe with Egypt and Indonesia reporting most of the infections. On the other hand, most reports of human infections by H7N9 and H5N6 have been limited in China. Despite the mild clinical illness and rapid recover in infected humans, H9N2 seems to have immense importance in terms of epidemiology of zoonotic influenza because the virus has been recognized as a potential enabler virus. The hypothesis was originated from the finding that H9N2 was a common denominator contributing to the genesis of H5N1, H5N6, H7N7, and H10N8, zoonotic viral strains as mentioned above, by providing whole sets of internal gene (PB2, PB1, PA, NP, M, and NS) [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B31" ref-type="bibr">31</xref>]. It has been reported that human infections by variant swine influenza viruses (SIVs) tend to result in mild clinical illness [<xref rid="B34" ref-type="bibr">34</xref>].</p></sec><sec><title>Avian Influenza, A Global Devastating Disease to Poultry Industry</title><p>As per pathotypes in terrestrial birds, avian influenza viruses can be classified into LPAIV and HPAIV. Aquatic wild bird has been known as a reservoir for LPAIV [<xref rid="B35" ref-type="bibr">35</xref>] and is much likely to show clinical resistance to HPAIV as well as LPAIV than is domestic poultry, even considering that H5N1 strain represents high morbidity and mortality in wild species [<xref rid="B36" ref-type="bibr">36</xref><xref rid="B37" ref-type="bibr">37</xref>]. In domestic poultry, HPAIVs cause severe disease, with fatality as high as 100%. In recent decade, global highly-pathogenic avian influenza (HPAI) outbreaks have been dominated by subtype H5 IAV strains (H5N1, H5N2, H5N6, and H5N8), all of which was derived from A/goose/Guangdong/1/96 (H5N1) [<xref rid="B38" ref-type="bibr">38</xref>]. Disease outbreaks of the A/goose/Guangdong/1/96 lineage viruses had been confined to the Asian continent before 2005. However, the viral spreads out of Asia were identified in Africa and Europe in 2005 (clade 2.2) and even in Americas in late 2014 (clade 2.3.4.4), which have been suspected of being spread by migratory birds [<xref rid="B39" ref-type="bibr">38</xref><xref rid="B39" ref-type="bibr">39</xref>].</p><p>The disease outbreaks have severely affected nation's poultry industry by causing tremendous economic losses including direct and indirect costs. Direct costs can be derived from (1) production losses by the disease itself and a series of actions to stabilize the onset of outbreaks (e.g., stamping-out, culling, and vaccination) and (2) control costs during and after disease outbreaks. The costs vary between countries because it is determined by the contribution of poultry industry to the national gross domestic product (GDP) and governmental control policies such as stamping-out and/or vaccination. Indirect costs include ripple effects, spill-over effects, and potential costs occurring with zoonotic events in related business and general public. Detailed definitions and examples for each cost are summarized in <xref ref-type="table" rid="T1">Table 1</xref>[<xref rid="B40" ref-type="bibr">40</xref>]. It is generally considered that the indirect impact is much greater than the direct impact because trade, tourism, and services that can be affected by public fear of zoonotic potential and international regulations have a large contribution to the national GDP.</p><p>Over 150 million poultry were killed in Asia during 2003–2004 HPAI H5N1 outbreaks and as a result, the total GDP losses were estimated at US $10 billion. Of countries affected by severe economic losses, Thailand suffered the largest economic losses recording total estimates of about US $1.2 billion. While the direct losses of Thailand (29 million birds, 14.5% of the poultry population) were the second-highest after Vietnam (44 million birds, 17.5% of the poultry population), trade losses were so severe that the largest total costs were recorded in Thailand, which was the inevitable result given that the country had been the world's fifth largest poultry exporter in the world. In HPAI outbreaks in United States during 2014–2015, economy-wide total loss estimates were $3.3 billion that includes $1.6 billion of direct costs from destroyed turkeys and egg production and partial indirect costs by negative knock-on effects on wholesale, retail, and food service sectors [<xref rid="B41" ref-type="bibr">41</xref>]. In Korea, the economic losses associated with HPAI outbreaks were largest in 2016–2017 since the first HPAI outbreak in 2003, with expected estimates of at least $435 million and maximum of $1.3 billion [<xref rid="B42" ref-type="bibr">42</xref>].</p><p>A survey of OIE member countries found that more than a quarter of the major disease outbreaks that occurred worldwide from 2000 to around 2016 (358 outbreaks) were occupied by avian influenza and those flu outbreaks were the most frequently related with trade issues [<xref rid="B43" ref-type="bibr">43</xref>]. When HPAI outbreaks occur in an exporting country, sudden unexpected trade bans are imposed by importing countries, which can result in severe economic losses to the exporter. To minimize the losses as well as prevent the viral spreads via trade commodities, despite the controversial issues about the applicability in other countries, the United States and European Union (EU) countries have been implementing ‘regionalization’ that reduces restrictions from whole country to smaller zones/regions. The regionalization should be based on comprehensive surveillance and risk assessments as recommended by the OIE Terrestrial Animal Health [<xref rid="B13" ref-type="bibr">13</xref>]. During HPAI outbreaks in United States during 2014–2017, successful applications of regionalization for the trade of poultry products have been reported; especially, at a single outbreak of H7N8 HPAI in the state of Indiana, many trading partners with United States did not impose restrictions as such large of a zone or wide of a range of products as they did during 2014–2015 HPAI outbreaks [<xref rid="B44" ref-type="bibr">44</xref>].</p></sec><sec><title>Pigs as Genetic Reservoirs for IAVs</title><p>While SIVs cause acute respiratory signs in pigs, the economic impacts of SIVs on swine industry as itself are not as high as those of HPAIVs on poultry industry because the infected pigs are frequently subclinical and characterized by low mortality (<1%) with rapid recovery in uncomplicated conditions [<xref rid="B45" ref-type="bibr">45</xref>]. However, substantial economic losses can occur in case of viral transmission of pandemic influenza from pigs to humans. Although the impacts of the 2009 H1N1 pandemic on global economy was estimated to be less than 1 percent of GDP, the costs for possible pandemics in the future could increase [<xref rid="B46" ref-type="bibr">46</xref>].</p><p>Cell surface receptors for both human (α2,3-linked sialic acids) and avian influenza viruses (α2,6-linked sialic acids) have been identified on swine respiratory epithelial cells, suggesting that pigs can be responsible for the emergence of pandemic influenza by serving as “mixing vessels” [<xref rid="B47" ref-type="bibr">47</xref>]. For the reason, swine influenza has attracted much more attentions in terms of public health rather than economic aspects. Recently, contrary to the prevailing belief, limited expression of α2,3-linked sialic acids on upper respiratory tracts of pigs has been identified in several studies [<xref rid="B48" ref-type="bibr">48</xref><xref rid="B49" ref-type="bibr">49</xref>]; accordingly, the importance of pigs as mixing vessels was somewhat diminished. However, the resemblance of receptor distribution (α2,3- and α2,6-linked sialic acids) between human and pig still poses substantial roles of pigs in emerging pandemic threats. Actually, H1N1pdm09 has a genomic constellation of swine origin; six segments (PB2, PB1, PA, HA, NP, and NS) from triple reassortants of North American swine lineage and the other two segments (M and NA) from a Eurasian swine lineage [<xref rid="B50" ref-type="bibr">50</xref>]. Moreover, following reverse zoonosis (spread from human to animal) of H1N1pdm09 to swine populations, as a consequence of reassortment of H1N1pdm09 with endemic swine H3N2, variant H3N2 (H3N2v) strains containing H1N1pdm09 internal genes (particularly, PA, NP, and M gene) have emerged and resulted in continuous human outbreaks in the United States since the first report in July 2011 [<xref rid="B33" ref-type="bibr">33</xref><xref rid="B51" ref-type="bibr">51</xref>]. The highest number of human outbreaks from July 2011 to December 2017 in the United States has been reported for H3N2v (H3N2v, n=434; H1N1v, n=21; H1N2v, n=13) and the case counts are as follows: 12 (2011), 309 (2012), 19 (2013), 3 (2014), 3 (2015), 18 (2016), and 62 (2017) (<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/swineflu/h3n2v-case-count.htm">https://www.cdc.gov/flu/swineflu/h3n2v-case-count.htm</ext-link>). Fortunately, it has been known that H3N2v strains reported until now have limited transmissibility between humans.</p><p>The pig population performs as genetic reservoirs for IAVs that had been prevalent in human population and manufacturers of new IAV strains. It has been reported that even though human seasonal H1N1 strains were replaced by H1N1pdm09, H1s of previous seasonal flu viruses still circulates among swine populations of North America, Europe, Asia, and South America [<xref rid="B9" ref-type="bibr">9</xref><xref rid="B52" ref-type="bibr">52</xref>]. Similarly, in China, the circulation of the parental strain of seasonal influenza virus H3N2 was confirmed in pigs long after the strain had been replaced by other strains in humans [<xref rid="B53" ref-type="bibr">53</xref>]. The genetic information of human seasonal influenza viruses preserved in swine population by region or country is summarized in <xref ref-type="table" rid="T2">Table 2</xref>. The longer human-origin IAVs circulate within pigs without exposure to humans, the more likely that immunological gaps will be made between older and younger generations, which makes that young people become immunologically vulnerable to previous season flu viruses, which they may encounter during their lifetime.</p></sec><sec><title>Vaccines Against IAV and Their World Usage in Animals</title><p>As the global human population continues to grow with the demand for animal proteins, the population density of domestic stocks such as chicken, ducks, and pigs has been increasing in many parts of the world including Asia and the United States [<xref rid="B54" ref-type="bibr">54</xref>]. Given the economic burdens for IAV outbreaks and the complexity of host-virus interplay, effective and thorough control strategies in animal sectors are crucial and necessary.</p><p>Vaccination is regarded as a cost-effective and efficient tool for the control of IAVs in animals. However, as a rule of thumb, a high level of biosecurity that includes all the related activities to control and prevent viral spreads such as changes of rearing style/facilities, disinfection, movement confinement must be accompanied with vaccination strategy based on sufficient surveillance data (<xref ref-type="fig" rid="F1">Fig. 1</xref>)[<xref rid="B55" ref-type="bibr">55</xref><xref rid="B56" ref-type="bibr">56</xref>]. Biosecurity measures also include interventions to reduce likelihood of IAV transmissions between humans and animals at animal-human interface such as abattoir and wild poultry markets in Asia [<xref rid="B57" ref-type="bibr">57</xref>] and additionally, pig agricultural fairs in the United States [<xref rid="B58" ref-type="bibr">58</xref>].</p><sec><title>Vaccine usages in poultry industry</title><p>Currently, vaccination of domestic poultry (chicken and turkey) is commonly implemented against HPAIV, H5/H7 LPAIV, and H9N2 LPAIV worldwide. Historically, emergency vaccination against HPAIV to control epizootics has been used in Mexico (H5N1, 1995–1995), Pakistan (H7N3, 1995–2004), Asia/ Africa/Europe (H5N1, 1996–continuing), and North Korea (H7N7, 2005) as an adjunction to stamping out programs. Meanwhile, China, Egypt, Vietnam, Indonesia, and Hong Kong have adopted routine vaccination of all poultry within a country against H5N1 HPAIV since 2002, which accounts for 99% of world total vaccine usage for HPAIV control from 2002 to 2010. The percent of vaccine usages and average coverage rate by countries as follows: (1) vaccine usage: China (90.99), Egypt (4.65), Hong Kong (0.08), Indonesia (2.32), and Vietnam (1.43) and (2) vaccine coverage rate: China (47.1), Egypt (69.9), Hong Kong (86.2), Indonesia (14.0), and Vietnam (52.3) [<xref rid="B59" ref-type="bibr">59</xref><xref rid="B60" ref-type="bibr">60</xref>].</p><p>The usage of vaccines containing H5 or H7 antigen against LPAIV was identified in six countries (Mexico, Italy, Guatemala, El Salvador, Portugal, and the United States) but the total amounts of doses (10.1 billion) are much smaller than those used for HPAI control (>113 billion). Due to relatively strong field impacts (decline in egg production and moderate to high mortality) among LPAIVs, H9N2 also has been controlled via vaccination in the Middle East and Asia including South Korea, Pakistan, and Israel [<xref rid="B59" ref-type="bibr">59</xref><xref rid="B60" ref-type="bibr">60</xref><xref rid="B61" ref-type="bibr">61</xref><xref rid="B62" ref-type="bibr">62</xref><xref rid="B63" ref-type="bibr">63</xref>].</p></sec><sec><title>Vaccine usages in swine industry</title><p>Vaccine usage to control swine influenza varies by countries; some countries use vaccination strategies, while others do not. For examples, SIV vaccination has been conducted extensively in the United States. On the contrary, in Korea, vaccines for SIV control have been rarely used despite the presence of a commercially available vaccine. Due to genetic diversity of circulating SIV strains, most commercial vaccines consist of multiple strains of subtype H1N1, H1N2, and H3N2. However, the fast evolution of field viruses could surpass the updates of commercial vaccines. Accordingly, combined use of herd-specific autogenous vaccine with other commercialized vaccines is implemented in some countries; about 20% of pig farms in the United States used the autogenous vaccines in 2006 [<xref rid="B64" ref-type="bibr">64</xref><xref rid="B65" ref-type="bibr">65</xref><xref rid="B66" ref-type="bibr">66</xref>]. However, compared to avian influenza viruses, it seems that vaccines against SIVs have not been utilized actively by swine veterinarians in many countries (at least in Asia) because deleterious effects on swine health by other major pathogens such as porcine reproductive syndrome virus and porcine circovirus are so severe that SIV has not been noticed as a disease that needs control.</p></sec></sec><sec><title>Considerations to be Successful Vaccination</title><p>For successful IAV vaccination, several factors related with vaccine, host, and human should be considered and harmonized (<xref ref-type="fig" rid="F1">Fig. 1</xref>)[<xref rid="B67" ref-type="bibr">67</xref><xref rid="B68" ref-type="bibr">68</xref>]. Most of currently licensed vaccines worldwide are the classic type of vaccine containing inactivated whole virus antigen formulated into mineral oil emulsions. Although several new effective generation vaccines have been developed [<xref rid="B69" ref-type="bibr">69</xref>], time will be required to resolve safety, efficacy, and cost issues in the field application and finally, for the vaccines to be licensed, which highlights the necessities of the effective and proper use of the classical inactivated vaccines.</p><p>High quality of vaccine and proper delivery to appropriate hosts are prerequisites for successful preventive vaccination, which can be assessed by antigen-specific response in vaccinated animals [<xref rid="B70" ref-type="bibr">70</xref>]. The surface glycoprotein HA is the major target of neutralizing antibodies (nAbs) against IAVs and the antibody quantities can be measured using hemagglutination inhibition (HI) assay utilizing the trait of the nAb that inhibits red blood cell agglutination. The major determinant of vaccine for success is antigenic match between circulating virus and vaccine strains. Vaccine strain homologous with field strains may confer the best protection against field strains of virus. For heterologous field strains, HI assay with host sera specific to vaccine antigens gives guidance to vaccine strain selection [<xref rid="B71" ref-type="bibr">71</xref>]. Moreover, it is anticipated that recent computational technologies such as antigenic cartography and antibody landscape modelling can provide fast, cost-effective and accurate analyses of candidate vaccine strains [<xref rid="B56" ref-type="bibr">56</xref>].</p><p>Inaccurate antigenic matching between vaccine strains and field strains leads to lower protective immunity and facilitates the selection of more resistant progenies or phenotypes to vaccine-induced immune conditions rather than elimination [<xref rid="B72" ref-type="bibr">72</xref>]. Consequently, the evolution of viral population into vaccine-escaping directions such as emergence of immune escaping mutants and change of dominant viral genotype occurs. Those phenomena have been observed both in avian virus [<xref rid="B73" ref-type="bibr">73</xref><xref rid="B74" ref-type="bibr">74</xref><xref rid="B75" ref-type="bibr">75</xref>] and SIVs [<xref rid="B76" ref-type="bibr">76</xref><xref rid="B77" ref-type="bibr">77</xref>] as well as in other viruses of industrial animals [<xref rid="B78" ref-type="bibr">78</xref><xref rid="B79" ref-type="bibr">79</xref><xref rid="B80" ref-type="bibr">80</xref><xref rid="B81" ref-type="bibr">81</xref>]. Incomplete vaccine coverage commonly observed in the fields also can be a critical contributor accelerating the evolution [<xref rid="B82" ref-type="bibr">82</xref>].</p><p>Recently, vaccine-associated enhanced respiratory disease (VAERD) has been identified in vaccinated pigs against swine IAVs. When pigs vaccinated with oil-in-water adjuvanted whole inactivated virus were challenged with viruses of same subtype but distinct antigenicity, more severe clinical signs and lesions of inflammation in lungs were observed compared to non-vaccinated pigs [<xref rid="B83" ref-type="bibr">83</xref><xref rid="B84" ref-type="bibr">84</xref><xref rid="B85" ref-type="bibr">85</xref>]. Multifactorial pathological mechanisms may be involved in VAERD. However, the vaccine-induced IgG antibodies that fails to cross-neutralize mismatched challenge strains seem to mediate enhanced pathogenesis [<xref rid="B86" ref-type="bibr">86</xref>].</p><p>Along with the good quality of vaccine, also crucial are host factors for successful preventive vaccination. Basically, animal herds to be vaccinated should not be in immunologically compromised conditions. Infections with immunosuppressive pathogens (e.g., infectious bursal disease and reticuloendotheliosis virus in chickens) and poor management practices (nutrition depletion, unhygienic condition, and etc.) can hamper vaccine-induced immune responses [<xref rid="B70" ref-type="bibr">70</xref><xref rid="B87" ref-type="bibr">87</xref>]. Maternally derived antibodies (MDA) can also interfere with vaccination. Additionally, it has been experimentally demonstrated that MDA from sows immunized with whole inactivated vaccine (WIV) can make their offspring become susceptible to VARED upon heterologous infection [<xref rid="B88" ref-type="bibr">88</xref>], which implies the importance of vaccine strain selection in pigs.</p></sec><sec><title>Limitations of WIV</title><p>Since the WIV stimulates mostly humoral response rather than cell-mediated response [<xref rid="B89" ref-type="bibr">89</xref>], sterilizing immunity is unlikely to occur in WIV vaccinated animals even to challenged viruses homologous with the vaccine strain; although clinical manifestations and viral shedding are significantly reduced with pre-immunization, the induced immunity cannot prevent infection [<xref rid="B90" ref-type="bibr">90</xref>]. Silent spread of HPAIV H5N1 without clinical signs in vaccinated flocks with WIV, which is the main reason for the reluctance to HPAIV vaccination in many countries and communities, is an example showing disadvantage of non-sterile immunity induced by WIV [<xref rid="B91" ref-type="bibr">91</xref><xref rid="B92" ref-type="bibr">92</xref>].</p><p>Dynamic changes in IAV epidemiology require corresponding rapid responses including updating of vaccine strains. Currently, most flu vaccines in human and animal medicine are produced in chicken embryos, which means that the vaccine strains need to grow well in chicken eggs. However, in case of HPAIVs, those viruses isolated from nature do not grow well in eggs because of early embryonic death. Therefore, attenuation procedure using reverse genetics is essential with following quality assurance and pathogenicity test in animals, which takes several months (about 22 weeks) to create new vaccine strains [<xref rid="B93" ref-type="bibr">93</xref>]. To overcome this and other several issues related with egg-based production systems such as egg supply and inflexibility with modern biotechnologies, cell-based vaccine production using fixed cell lines has been developed [<xref rid="B94" ref-type="bibr">94</xref><xref rid="B95" ref-type="bibr">95</xref>]. In 2016, Food and Drug Administration of the United States approved the use of cell-based viruses for the production of human influenza vaccine (Flucelvax) [<xref rid="B96" ref-type="bibr">96</xref><xref rid="B97" ref-type="bibr">97</xref>].</p><p>Due to non-infectious nature of killed antigen, delivery of WIV must be provided via intramuscular or intradermal routes. Considering high density rearing and rapid turnover rate of livestock, especially pigs and poultry in industrial settings, the individual vaccination is highly laborious and error prone process, leading to incomplete herd immunity and vaccine failures. On the contrary, mass application with reduced vaccination time and labor cost is available using water supply or aerosol spray of infectious viruses such as attenuated live viruses [<xref rid="B98" ref-type="bibr">98</xref>] and recombinant Newcastle disease viruses (NDV) [<xref rid="B99" ref-type="bibr">99</xref><xref rid="B100" ref-type="bibr">100</xref><xref rid="B101" ref-type="bibr">101</xref><xref rid="B102" ref-type="bibr">102</xref>].</p></sec><sec><title>Next Generation IAV Vaccines in Avian and Swine Industry</title><sec><title>Vectored vaccines</title><p>Vectored vaccine has been investigated extensively using various viral vectors: human adenovirus 5 and pseudorabies virus in pigs [<xref rid="B103" ref-type="bibr">103</xref>]; fowlpox virus (FPV), NDV, herpesvirus of turkey (HVT), duck enteritis virus and etc. in poultry [<xref rid="B104" ref-type="bibr">104</xref>]. Among them, vectored vaccines using FPV, HVT, and NDV have been commercially available in more than one country [<xref rid="B104" ref-type="bibr">104</xref>]. Vectored vaccine uses viral vectors to deliver target protein to host's immune system. HA protein is mainly targeted in vaccines against IAV. Because the vectors infect host cells, those safely activate both humoral and cell-mediated immunity. However, if the host have maternal antibody or preexisting immunity to vector, the vectored vaccines fail to immunize host against IAV. For example, because routine vaccination programme against NDV (avian paramyxovirus serotype 1, APMV-1) has been implemented in many countries, most commercial chickens have pre-existing immunity against NDV vectors. As alternative measures, other serotypes of APMV having low cross-reactivity with anti-NDV antibody such as APMV-2, APMV-3, APMV-6, and APMV-10 have been proposed for candidate vectors [<xref rid="B105" ref-type="bibr">105</xref><xref rid="B106" ref-type="bibr">106</xref>]. For the same reason, those type of vaccine cannot be administered multiple times; in a prime boost strategy, vectored vaccine should be applied first, followed by other types of vaccine for boosting purpose. Distinct characteristics of vaccines can be exhibited depending on the nature of the viral vectors. For example, FPV vectors are not efficiently interrupted by MDA and can confer protection after single vaccination on 1-day-old chicks [<xref rid="B107" ref-type="bibr">107</xref><xref rid="B108" ref-type="bibr">108</xref>]. Like avian influenza viruses, the major infection route of NDV vectors is respiratory tract, which enables the mass vaccination via aerosol spray as mentioned [<xref rid="B99" ref-type="bibr">99</xref><xref rid="B109" ref-type="bibr">109</xref>].</p></sec><sec><title>RNA vaccines</title><p>RNA vaccines can be classified into two types: one is conventional mRNA vaccines and the other is self-amplifying mRNA (SAM) vaccines. The mRNA containing gene of interest that resembles host cell mRNA is the required factor for the conventional mRNA vaccine. The genome of RNA viruses such as alphavirus engineered not to produce viral progenies has been applied in SAM vaccines. Because the gene of target is substituted for viral structural gene which is essential for viral packing, the RNA replicon cannot produce infectious viral particles but expresses high levels of target antigen via self-amplification in host cells [<xref rid="B110" ref-type="bibr">110</xref>]. In contrast to DNA, RNA only needs to cross one barrier, plasma membrane, to express target proteins and can be actively taken up by dendritic cells or other cell types via receptor-mediated endocytosis [<xref rid="B111" ref-type="bibr">111</xref>], which enables the vaccines to be administered via intramuscular or intradermal route. Delivered RNAs are recognized by innate immunity using pattern recognition receptors, which leads to subsequent activation of cell mediated and humoral immune response [<xref rid="B112" ref-type="bibr">112</xref>]. Recently, significant improvements in overall process to make RNA vaccines such as synthesis, stability, purification and delivery of RNA have been achieved [<xref rid="B113" ref-type="bibr">113</xref><xref rid="B114" ref-type="bibr">114</xref><xref rid="B115" ref-type="bibr">115</xref><xref rid="B116" ref-type="bibr">116</xref><xref rid="B117" ref-type="bibr">117</xref><xref rid="B118" ref-type="bibr">118</xref>]. Moreover, the simple concept of the vaccine will make it feasible to rapidly reflect the contemporary field IAV strains (estimated as 6-8 weeks from sequence data acquisition to quality control test) [<xref rid="B118" ref-type="bibr">118</xref>].</p><p>The RNA vaccines using SAM technology for swine influenza have been commercialized in the United States and the number of doses used alongside autogenous vaccines during 2008-2011 accounted for about 50% of total doses of swine influenza vaccines [<xref rid="B56" ref-type="bibr">56</xref>]. The SAM vaccines for avian influenza were also recently licensed in the United States [<xref rid="B104" ref-type="bibr">104</xref>]. For conventional mRNA vaccines, although there is no commercialized product for IAV yet, its high efficacy has been demonstrated in mouse, ferret, and pig models [<xref rid="B118" ref-type="bibr">118</xref>]. The efficacy in poultry species remains to be tested. Most recently, effective seroconversion after the mRNA vaccination against H10N8 and H7N9 has been demonstrated in monkeys and humans [<xref rid="B119" ref-type="bibr">119</xref>].</p></sec><sec><title>Universal vaccines</title><p>The concept of universal vaccine is to cover all subtypes of IAVs. Developing such a vaccine that induce broadly cross-reactive immunity would be beneficial in both human and animal medicines considering dynamic epidemiology and genetic diversity of IAVs. Highly conserved antigenic domain has been the target for the development of universal IAV vaccines. Stalk domain relatively conserved compared to globular head domain in HA and M2 ion channel has been investigated extensively for the promising vaccine candidates [<xref rid="B120" ref-type="bibr">120</xref><xref rid="B121" ref-type="bibr">121</xref><xref rid="B122" ref-type="bibr">122</xref>]. NP, PA, and M1 have been also considered to provide heterosubtypic protection. However, as demonstrated by many experimental challenge studies, cross protection conferred by universal IAV vaccine is weak and depends mostly on cytotoxic T lymphocyte responses with the minimal effect of nAbs [<xref rid="B123" ref-type="bibr">123</xref>]. Unfortunately, in pigs vaccinated with universal vaccines based on HA stalk domain [<xref rid="B86" ref-type="bibr">86</xref>] and extracellular M2 protein [<xref rid="B124" ref-type="bibr">124</xref>], exacerbated clinical signs and even deaths were observed, which suggests the careful clinical application of universal vaccine in pigs.</p></sec><sec><title>DIVA vaccines</title><p>Most types of vaccine except live attenuated vaccine can be compatible with differentiating infected from vaccinated animals (DIVA) strategies, which is essential for the effective disease control in animals. For example, the presence of antibodies against nonstructural protein (mainly NS1), which is absent in animals vaccinated with inactivated IAV can be biomarkers for viral infection [<xref rid="B125" ref-type="bibr">125</xref>]. In case of vaccines utilizing particular genes or proteins (mainly HA or NA), only specific immune response against targeted protein is induced and thereby can be used for DIVA. Those vaccines involve nucleic acid (DNA/RNA) vaccines, subunit vaccines, peptide vaccines, virus like particles, and vectored vaccines. Although there exist several live attenuated vaccines available for DIVA (e.g., neuraminidase deleted IAV vaccine), it is not clear that whether those vaccines can be used in the fields [<xref rid="B126" ref-type="bibr">126</xref><xref rid="B127" ref-type="bibr">127</xref>].</p></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Continuous evolution of IAV is not a risk confined to particular species as described in this review. Human outbreaks by zoonotic and pandemic influenza virus at animal-human borders have been occurring worldwide with regular seasonal flu outbreaks and human influenza viruses have been introduced to swine by reverse zoonosis. Recent HPAI outbreaks have been severely damaging poultry industry and human infections by the HPAIVs have raised concerns for public health. Taking into consideration of dynamic interplay of IAVs between human and animal sectors, vaccine is considered a promising preventive or control tool that could make synergistic effects when combined with proper biosecurity practices.</p><p>Different vaccination strategies against HPAI have been used as per country policy. While some countries adopted regular HPAI vaccination, others used the HPAI vaccine only in an emergency and the others stick to stamping-out policy without using vaccines. In South Korea, despite the repetitive HPAI outbreaks with continued economic losses, the government is reluctant to use HPAI vaccines behind the fear of becoming endemic status and concerns about impact on trade. Countries such as China, Indonesia, Egypt, and Vietnam that have implemented vaccination against HPAIV still remain endemic. However, the vaccine in these countries was introduced after HPAI become enzootic. Furthermore, their inadequate vaccine coverage seems to attribute to continued HPAI outbreaks and the emergence of antigenic variant strains. Rather, trade losses by HPAI outbreaks can be minimized through rapid stabilization of outbreaks by the effective use of HPAI vaccines. Those can be accomplished via harmonization between emergency ring vaccination with stamping out policy and high levels of biosecurity accompanied by thorough surveillance. The importance of pigs as genetic reservoirs of human and avian lineages of IAVs has not been taken seriously in many Asian countries including Korea. However, in the One Health concept, it seems that SIVs in Asian pig populations should be monitored and controlled by the supports of governments, field veterinarians, and swine industry.</p><p>Over the recent decades, various experimental vaccines against IAV have been developed to enhance the vaccine efficacy and safety. WIV vaccines are the most widely used and safe vaccine but there are concerns about cross protection and low efficient viral elimination. On the contrary, live attenuated vaccines are considered the most efficacious among existing vaccine types due to rather broad coverage of protection and rapid viral clearance but have safety problems related with reversion to virulence. The promising next generation vaccine candidates that have strength both in efficacy and safety seem to be vectored and RNA vaccines. In addition, under the era that requires rapid response against IAV threats, the flexibility of these two vaccines is of great advantage. Every vaccine developed and under development has its pros and cons and there is no absolute vaccine that can be applied to every host and condition effectively at the best performance. In practical aspects, vaccines that are highly compatible with massive immunization methods such as aerosol spray and water supply and DIVA are highly recommended for vaccine usages in animals under industrial settings. Further, complementary vaccine usage (e.g., NDV vectored vaccine for prime and WIV vaccine for boosting) can be an attractive alternative strategy to prevent and control IAVs. We believe that recent developments of vaccine technology will bring us more efficient tools for the prevention and control of IAVs.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No potential conflict of interest relevant to this article was reported.</p></fn><fn fn-type="supported-by"><p>This work was supported in part by a grant from the Konkuk university research foundation 2017.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Bean</surname><given-names>WJ</given-names></name><name><surname>Gorman</surname><given-names>OT</given-names></name><name><surname>Chambers</surname><given-names>TM</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group><article-title>Evolution and ecology of influenza A viruses</article-title><source>Microbiol Rev</source><year>1992</year><volume>56</volume><fpage>152</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">1579108</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Govorkova</surname><given-names>EA</given-names></name></person-group><article-title>Continuing challenges in influenza</article-title><source>Ann N Y Acad Sci</source><year>2014</year><volume>1323</volume><fpage>115</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">24891213</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauldwell</surname><given-names>AV</given-names></name><name><surname>Long</surname><given-names>JS</given-names></name><name><surname>Moncorge</surname><given-names>O</given-names></name><name><surname>Barclay</surname><given-names>WS</given-names></name></person-group><article-title>Viral determinants of influenza A virus host range</article-title><source>J Gen Virol</source><year>2014</year><volume>95</volume><fpage>1193</fpage><lpage>1210</lpage><pub-id pub-id-type="pmid">24584475</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>KR</given-names></name><name><surname>Richard</surname><given-names>M</given-names></name><name><surname>Verhagen</surname><given-names>JH</given-names></name><etal></etal></person-group><article-title>One health, multiple challenges: the inter-species transmission of influenza A virus</article-title><source>One Health</source><year>2015</year><volume>1</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">26309905</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Ren</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Sudden increase in human infection with avian influenza A(H7N9) virus in China, September-December 2016</article-title><source>Western Pac Surveill Response J</source><year>2017</year><volume>8</volume><fpage>6</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">28409054</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iuliano</surname><given-names>AD</given-names></name><name><surname>Jang</surname><given-names>Y</given-names></name><name><surname>Jones</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Increase in human infections with avian influenza A(H7N9) virus during the fifth epidemic, October 2016-February 2017</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2017</year><volume>66</volume><fpage>254</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">28278147</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>GJ</given-names></name><name><surname>Vijaykrishna</surname><given-names>D</given-names></name><name><surname>Bahl</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic</article-title><source>Nature</source><year>2009</year><volume>459</volume><fpage>1122</fpage><lpage>1125</lpage><pub-id pub-id-type="pmid">19516283</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garten</surname><given-names>RJ</given-names></name><name><surname>Davis</surname><given-names>CT</given-names></name><name><surname>Russell</surname><given-names>CA</given-names></name><etal></etal></person-group><article-title>Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans</article-title><source>Science</source><year>2009</year><volume>325</volume><fpage>197</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">19465683</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>A</given-names></name><name><surname>Awada</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>I</given-names></name><etal></etal></person-group><article-title>Review of influenza A virus in swine worldwide: a call for increased surveillance and research</article-title><source>Zoonoses Public Health</source><year>2014</year><volume>61</volume><fpage>4</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">23556412</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>M</given-names></name><name><surname>Yen</surname><given-names>HL</given-names></name></person-group><article-title>Animal and human influenzas</article-title><source>Rev Sci Tech</source><year>2014</year><volume>33</volume><fpage>539</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">25707182</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>AC</given-names></name><name><surname>Fragaszy</surname><given-names>EB</given-names></name><name><surname>Bermingham</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study</article-title><source>Lancet Respir Med</source><year>2014</year><volume>2</volume><fpage>445</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">24717637</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horby</surname><given-names>PW</given-names></name></person-group><article-title>Community studies of influenza: new knowledge, new questions</article-title><source>Lancet Respir Med</source><year>2014</year><volume>2</volume><fpage>430</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">24717636</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="book"><collab>World Organisation for Animal Health</collab><source>Terrestrial Animal Health Code [Internet]</source><publisher-loc>Paris</publisher-loc><publisher-name>World Organisation for Animal Health</publisher-name><year>2017</year><date-in-citation content-type="access-date">cited 2017 Oct 28</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.oie.int/international-standard-setting/terrestrial-code/access-online">http://www.oie.int/international-standard-setting/terrestrial-code/access-online</ext-link></comment></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>YY</given-names></name><name><surname>Ke</surname><given-names>CW</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><etal></etal></person-group><article-title>Novel reassortant avian influenza A(H5N6) viruses in humans, Guangdong, China, 2015</article-title><source>Emerg Infect Dis</source><year>2016</year><volume>22</volume><fpage>1507</fpage><lpage>1509</lpage><pub-id pub-id-type="pmid">27331418</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>DC</given-names></name><name><surname>Uyeki</surname><given-names>TM</given-names></name><name><surname>Jadhao</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>4201</fpage><lpage>4212</lpage><pub-id pub-id-type="pmid">15767421</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Senne</surname><given-names>DA</given-names></name><name><surname>Linares</surname><given-names>JA</given-names></name><etal></etal></person-group><article-title>Characterization of recent H5 subtype avian influenza viruses from US poultry</article-title><source>Avian Pathol</source><year>2004</year><volume>33</volume><fpage>288</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">15223555</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Bertran</surname><given-names>K</given-names></name><name><surname>Kwon</surname><given-names>JH</given-names></name><name><surname>Swayne</surname><given-names>DE</given-names></name></person-group><article-title>Evolution, global spread, and pathogenicity of highly pathogenic avian influenza H5Nx clade 2.3.4.4</article-title><source>J Vet Sci</source><year>2017</year><volume>18</volume><fpage>269</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">28859267</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Torchetti</surname><given-names>MK</given-names></name><name><surname>Winker</surname><given-names>K</given-names></name><name><surname>Ip</surname><given-names>HS</given-names></name><name><surname>Song</surname><given-names>CS</given-names></name><name><surname>Swayne</surname><given-names>DE</given-names></name></person-group><article-title>Intercontinental spread of Asian-origin H5N8 to North America through beringia by migratory birds</article-title><source>J Virol</source><year>2015</year><volume>89</volume><fpage>6521</fpage><lpage>6524</lpage><pub-id pub-id-type="pmid">25855748</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>T</given-names></name><name><surname>Capua</surname><given-names>I</given-names></name><name><surname>Dauphin</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>FAO-OIE-WHO Joint Technical Consultation on avian influenza at the human-animal interface</article-title><source>Influenza Other Respir Viruses</source><year>2010</year><volume>4</volume><issue>Suppl 1</issue><fpage>1</fpage><lpage>29</lpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>DU</given-names></name><name><surname>Otte</surname><given-names>MJ</given-names></name><name><surname>Roland-Holst</surname><given-names>D</given-names></name><name><surname>Zilberman</surname><given-names>D</given-names></name></person-group><article-title>A one health perspective on HPAI H5N1 in the Greater Mekong sub-region</article-title><source>Comp Immunol Microbiol Infect Dis</source><year>2013</year><volume>36</volume><fpage>309</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">23260375</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="book"><collab>World Health Organization</collab><source>Fact sheets 211 influenza (seasonal) [Internet]</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2016</year><date-in-citation content-type="access-date">cited 2017 Oct 15</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs211/en">http://www.who.int/mediacentre/factsheets/fs211/en</ext-link></comment></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinari</surname><given-names>NA</given-names></name><name><surname>Ortega-Sanchez</surname><given-names>IR</given-names></name><name><surname>Messonnier</surname><given-names>ML</given-names></name><etal></etal></person-group><article-title>The annual impact of seasonal influenza in the US: measuring disease burden and costs</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>5086</fpage><lpage>5096</lpage><pub-id pub-id-type="pmid">17544181</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="book"><collab>World Health Organization</collab><source>Influenza update [Internet]</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2017</year><date-in-citation content-type="access-date">cited 2017 Oct 15</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/influenza/surveillance_monitoring/updates/latest_update_GIP_surveillance/en">http://www.who.int/influenza/surveillance_monitoring/updates/latest_update_GIP_surveillance/en</ext-link></comment></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>JK</given-names></name><name><surname>Morens</surname><given-names>DM</given-names></name></person-group><article-title>1918 Influenza: the mother of all pandemics</article-title><source>Emerg Infect Dis</source><year>2006</year><volume>12</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">16494711</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>JK</given-names></name><name><surname>Reid</surname><given-names>AH</given-names></name><name><surname>Lourens</surname><given-names>RM</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Jin</surname><given-names>G</given-names></name><name><surname>Fanning</surname><given-names>TG</given-names></name></person-group><article-title>Characterization of the 1918 influenza virus polymerase genes</article-title><source>Nature</source><year>2005</year><volume>437</volume><fpage>889</fpage><lpage>893</lpage><pub-id pub-id-type="pmid">16208372</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anhlan</surname><given-names>D</given-names></name><name><surname>Grundmann</surname><given-names>N</given-names></name><name><surname>Makalowski</surname><given-names>W</given-names></name><name><surname>Ludwig</surname><given-names>S</given-names></name><name><surname>Scholtissek</surname><given-names>C</given-names></name></person-group><article-title>Origin of the 1918 pandemic H1N1 influenza A virus as studied by codon usage patterns and phylogenetic analysis</article-title><source>RNA</source><year>2011</year><volume>17</volume><fpage>64</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">21068184</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>AH</given-names></name><name><surname>Fanning</surname><given-names>TG</given-names></name><name><surname>Janczewski</surname><given-names>TA</given-names></name><name><surname>Lourens</surname><given-names>RM</given-names></name><name><surname>Taubenberger</surname><given-names>JK</given-names></name></person-group><article-title>Novel origin of the 1918 pandemic influenza virus nucleoprotein gene</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>12462</fpage><lpage>12470</lpage><pub-id pub-id-type="pmid">15507633</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>MJ</given-names></name><name><surname>Gibbs</surname><given-names>AJ</given-names></name></person-group><article-title>Molecular virology: was the 1918 pandemic caused by a bird flu?</article-title><source>Nature</source><year>2006</year><volume>440</volume><elocation-id>E8</elocation-id><pub-id pub-id-type="pmid">16641948</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanning</surname><given-names>TG</given-names></name><name><surname>Slemons</surname><given-names>RD</given-names></name><name><surname>Reid</surname><given-names>AH</given-names></name><name><surname>Janczewski</surname><given-names>TA</given-names></name><name><surname>Dean</surname><given-names>J</given-names></name><name><surname>Taubenberger</surname><given-names>JK</given-names></name></person-group><article-title>1917 avian influenza virus sequences suggest that the 1918 pandemic virus did not acquire its hemagglutinin directly from birds</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>7860</fpage><lpage>7862</lpage><pub-id pub-id-type="pmid">12097598</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>JK</given-names></name><name><surname>Kash</surname><given-names>JC</given-names></name></person-group><article-title>Influenza virus evolution, host adaptation, and pandemic formation</article-title><source>Cell Host Microbe</source><year>2010</year><volume>7</volume><fpage>440</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">20542248</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title>Current situation of H9N2 subtype avian influenza in China</article-title><source>Vet Res</source><year>2017</year><volume>48</volume><fpage>49</fpage><pub-id pub-id-type="pmid">28915920</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epperson</surname><given-names>S</given-names></name><name><surname>Jhung</surname><given-names>M</given-names></name><name><surname>Richards</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012</article-title><source>Clin Infect Dis</source><year>2013</year><volume>57</volume><issue>Suppl 1</issue><fpage>S4</fpage><lpage>S11</lpage><pub-id pub-id-type="pmid">23794729</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>AS</given-names></name><name><surname>Walia</surname><given-names>RR</given-names></name><name><surname>Nolting</surname><given-names>JM</given-names></name><etal></etal></person-group><article-title>Influenza A (H3N2) virus in swine at agricultural fairs and transmission to humans, Michigan and Ohio, USA, 2016</article-title><source>Emerg Infect Dis</source><year>2017</year><volume>23</volume><fpage>1551</fpage><lpage>1555</lpage><pub-id pub-id-type="pmid">28820376</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="book"><collab>World Health Organization</collab><source>Influenza: monthly risk assessment summary (7 December 2017) [Internet]</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2017</year><date-in-citation content-type="access-date">cited 2017 Dec 7</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment/en">http://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment/en</ext-link></comment></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>Stallknecht</surname><given-names>DE</given-names></name><name><surname>Slemons</surname><given-names>RD</given-names></name><etal></etal></person-group><article-title>The enigma of the apparent disappearance of Eurasian highly pathogenic H5 clade 2.3.4.4 influenza A viruses in North American waterfowl</article-title><source>Proc Natl Acad Sci U S A</source><year>2016</year><volume>113</volume><fpage>9033</fpage><lpage>9038</lpage><pub-id pub-id-type="pmid">27457948</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>TM</given-names></name><name><surname>Bousfield</surname><given-names>RB</given-names></name><name><surname>Bissett</surname><given-names>LA</given-names></name><etal></etal></person-group><article-title>Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002</article-title><source>Avian Pathol</source><year>2004</year><volume>33</volume><fpage>492</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">15545029</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvaux</surname><given-names>S</given-names></name><name><surname>Marx</surname><given-names>N</given-names></name><name><surname>Ong</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Highly pathogenic avian influenza virus (H5N1) outbreak in captive wild birds and cats, Cambodia</article-title><source>Emerg Infect Dis</source><year>2009</year><volume>15</volume><fpage>475</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">19239769</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harfoot</surname><given-names>R</given-names></name><name><surname>Webby</surname><given-names>RJ</given-names></name></person-group><article-title>H5 influenza, a global update</article-title><source>J Microbiol</source><year>2017</year><volume>55</volume><fpage>196</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">28243942</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="book"><collab>World Health Organization</collab><source>H5N1 avian influenza: timeline of major events [Internet]</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>2014</year><date-in-citation content-type="access-date">cited 2017 Nov 14</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/influenza/human_animal_interface/en">http://www.who.int/influenza/human_animal_interface/en</ext-link></comment></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="book"><collab>World Organisation for Animal Health</collab><source>Economic analysis: prevention versus outbreak costs [Internet]</source><publisher-loc>Paris</publisher-loc><publisher-name>World Organisation for Animal Health</publisher-name><year>2007</year><date-in-citation content-type="access-date">cited 2017 Oct 28</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.oie.int/fileadmin/Home/eng/Support_to_OIE_Members/docs/pdf/OIE_-_Cost-Benefit_Analysis__Part_I_.pdf">http://www.oie.int/fileadmin/Home/eng/Support_to_OIE_Members/docs/pdf/OIE_-_Cost-Benefit_Analysis__Part_I_.pdf</ext-link></comment></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="book"><collab>U.S. Government Accountability Office</collab><source>Avian influenza: USDA has taken actions to reduce risks but needs a plan to evaluate its efforts [Internet]</source><publisher-loc>Washington, DC</publisher-loc><publisher-name>U.S. Government Accountability Office</publisher-name><year>2017</year><date-in-citation content-type="access-date">cited 2017 Nov 4</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.gao.gov/assets/690/684086.pdf">http://www.gao.gov/assets/690/684086.pdf</ext-link></comment></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="book"><collab>Hyundai Research Institute</collab><source>Spread of AIV at utmost speed ever and the resulting economic losses [Internet]</source><publisher-loc>Seoul</publisher-loc><publisher-name>Hyundai Research Institute</publisher-name><year>2016</year><date-in-citation content-type="access-date">[cited 2017 Nov 1</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://hri.co.kr/upload/publication/2016121494516[1].pdf">http://hri.co.kr/upload/publication/2016121494516[1].pdf</ext-link></comment></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rushton</surname><given-names>J</given-names></name><name><surname>Gilbert</surname><given-names>W</given-names></name></person-group><source>The economics of animal health: direct and indirect costs of animal disease outbreaks [Internet]</source><publisher-loc>Paris</publisher-loc><publisher-name>World Organisation for Animal Health</publisher-name><year>2016</year><date-in-citation content-type="access-date">cited 2017 Nov 4</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.oie.int/eng/session2016/sg84/02-Monday/Rushton_Technical_Paper_TT1_final_revision.pdf">https://www.oie.int/eng/session2016/sg84/02-Monday/Rushton_Technical_Paper_TT1_final_revision.pdf</ext-link></comment></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swayne</surname><given-names>DE</given-names></name><name><surname>Hill</surname><given-names>RE</given-names></name><name><surname>Clifford</surname><given-names>J</given-names></name></person-group><article-title>Safe application of regionalization for trade in poultry and poultry products during highly pathogenic avian influenza outbreaks in the USA</article-title><source>Avian Pathol</source><year>2017</year><volume>46</volume><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">27817200</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>JJ</given-names></name><name><surname>Karriker</surname><given-names>LA</given-names></name><name><surname>Ramirez</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>KJ</given-names></name><name><surname>Stevenson</surname><given-names>GW</given-names></name></person-group><source>Diseases of swine</source><edition>10th ed</edition><publisher-loc>Chichester</publisher-loc><publisher-name>Wiley-Blackwell</publisher-name><year>2012</year></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>RD</given-names></name><name><surname>Keogh-Brown</surname><given-names>MR</given-names></name></person-group><article-title>Macroeconomic impact of pandemic influenza and associated policies in Thailand, South Africa and Uganda</article-title><source>Influenza Other Respir Viruses</source><year>2013</year><volume>7</volume><issue>Suppl 2</issue><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">24034487</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Couceiro</surname><given-names>JN</given-names></name><name><surname>Kelm</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Molecular basis for the generation in pigs of influenza A viruses with pandemic potential</article-title><source>J Virol</source><year>1998</year><volume>72</volume><fpage>7367</fpage><lpage>7373</lpage><pub-id pub-id-type="pmid">9696833</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trebbien</surname><given-names>R</given-names></name><name><surname>Larsen</surname><given-names>LE</given-names></name><name><surname>Viuff</surname><given-names>BM</given-names></name></person-group><article-title>Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs</article-title><source>Virol J</source><year>2011</year><volume>8</volume><fpage>434</fpage><pub-id pub-id-type="pmid">21902821</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>RW</given-names></name><name><surname>Karamanska</surname><given-names>R</given-names></name><name><surname>Van Poucke</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Infection of swine ex vivo tissues with avian viruses including H7N9 and correlation with glycomic analysis</article-title><source>Influenza Other Respir Viruses</source><year>2013</year><volume>7</volume><fpage>1269</fpage><lpage>1282</lpage><pub-id pub-id-type="pmid">24001121</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><collab>Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team</collab><person-group person-group-type="author"><name><surname>Dawood</surname><given-names>FS</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Emergence of a novel swine-origin influenza A (H1N1) virus in humans</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><fpage>2605</fpage><lpage>2615</lpage><pub-id pub-id-type="pmid">19423869</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajao</surname><given-names>DS</given-names></name><name><surname>Walia</surname><given-names>RR</given-names></name><name><surname>Campbell</surname><given-names>B</given-names></name><etal></etal></person-group><article-title>Reassortment between Swine H3N2 and 2009 pandemic H1N1 in the United States resulted in influenza A viruses with diverse genetic constellations with variable virulence in pigs</article-title><source>J Virol</source><year>2017</year><volume>91</volume><fpage>e01763</fpage><lpage>e01716</lpage><pub-id pub-id-type="pmid">27928015</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>MI</given-names></name><name><surname>Gramer</surname><given-names>MR</given-names></name><name><surname>Vincent</surname><given-names>AL</given-names></name><name><surname>Holmes</surname><given-names>EC</given-names></name></person-group><article-title>Global transmission of influenza viruses from humans to swine</article-title><source>J Gen Virol</source><year>2012</year><volume>93</volume><fpage>2195</fpage><lpage>2203</lpage><pub-id pub-id-type="pmid">22791604</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shortridge</surname><given-names>KF</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Butterfield</surname><given-names>WK</given-names></name><name><surname>Campbell</surname><given-names>CH</given-names></name></person-group><article-title>Persistence of Hong Kong influenza virus variants in pigs</article-title><source>Science</source><year>1977</year><volume>196</volume><fpage>1454</fpage><lpage>1455</lpage><pub-id pub-id-type="pmid">867041</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>M</given-names></name><name><surname>Conchedda</surname><given-names>G</given-names></name><name><surname>Van Boeckel</surname><given-names>TP</given-names></name><etal></etal></person-group><article-title>Income disparities and the global distribution of intensively farmed chicken and pigs</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><elocation-id>e0133381</elocation-id><pub-id pub-id-type="pmid">26230336</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Swayne</surname><given-names>DE</given-names></name><name><surname>Kapczynski</surname><given-names>DR</given-names></name></person-group><chapter-title>Vaccines, vaccination, and immunology for avian influenza viruses in poultry</chapter-title><person-group person-group-type="editor"><name><surname>Swayne</surname><given-names>DE</given-names></name></person-group><source>Avian influenza</source><publisher-loc>Ames, IW</publisher-loc><publisher-name>Blackwell Publishing</publisher-name><year>2008</year><fpage>407</fpage><lpage>451</lpage></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>AL</given-names></name><name><surname>Perez</surname><given-names>DR</given-names></name><name><surname>Rajao</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Influenza A virus vaccines for swine</article-title><source>Vet Microbiol</source><year>2017</year><volume>206</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">27923501</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>JS</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name><name><surname>Wu</surname><given-names>JT</given-names></name><etal></etal></person-group><article-title>Interventions to reduce zoonotic and pandemic risks from avian influenza in Asia</article-title><source>Lancet Infect Dis</source><year>2016</year><volume>16</volume><fpage>252</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">26654122</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>AS</given-names></name><name><surname>Nolting</surname><given-names>JM</given-names></name><name><surname>Nelson</surname><given-names>SW</given-names></name><name><surname>Slemons</surname><given-names>RD</given-names></name></person-group><article-title>Subclinical influenza virus A infections in pigs exhibited at agricultural fairs, Ohio, USA, 2009-2011</article-title><source>Emerg Infect Dis</source><year>2012</year><volume>18</volume><fpage>1945</fpage><lpage>1950</lpage><pub-id pub-id-type="pmid">23171654</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swayne</surname><given-names>DE</given-names></name></person-group><article-title>Impact of vaccines and vaccination on global control of avian influenza</article-title><source>Avian Dis</source><year>2012</year><volume>56</volume><issue>4 Suppl</issue><fpage>818</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">23402099</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swayne</surname><given-names>DE</given-names></name><name><surname>Pavade</surname><given-names>G</given-names></name><name><surname>Hamilton</surname><given-names>K</given-names></name><name><surname>Vallat</surname><given-names>B</given-names></name><name><surname>Miyagishima</surname><given-names>K</given-names></name></person-group><article-title>Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination</article-title><source>Rev Sci Tech</source><year>2011</year><volume>30</volume><fpage>839</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">22435196</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Song</surname><given-names>CS</given-names></name></person-group><article-title>H9N2 avian influenza virus in Korea: evolution and vaccination</article-title><source>Clin Exp Vaccine Res</source><year>2013</year><volume>2</volume><fpage>26</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">23596587</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perk</surname><given-names>S</given-names></name><name><surname>Golender</surname><given-names>N</given-names></name><name><surname>Banet-Noach</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Phylogenetic analysis of hemagglutinin, neuraminidase, and nucleoprotein genes of H9N2 avian influenza viruses isolated in Israel during the 2000-2005 epizootic</article-title><source>Comp Immunol Microbiol Infect Dis</source><year>2009</year><volume>32</volume><fpage>221</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">18249445</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeem</surname><given-names>K</given-names></name><name><surname>Siddique</surname><given-names>N</given-names></name></person-group><article-title>Use of strategic vaccination for the control of avian influenza in Pakistan</article-title><source>Dev Biol (Basel)</source><year>2006</year><volume>124</volume><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">16447505</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>NS</given-names></name><name><surname>Russell</surname><given-names>CA</given-names></name><name><surname>Langat</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>The global antigenic diversity of swine influenza A viruses</article-title><source>Elife</source><year>2016</year><volume>5</volume><elocation-id>e12217</elocation-id><pub-id pub-id-type="pmid">27113719</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>W</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Pu</surname><given-names>J</given-names></name></person-group><article-title>Epidemic status of Swine influenza virus in china</article-title><source>Indian J Microbiol</source><year>2014</year><volume>54</volume><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">24426160</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>AL</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Lager</surname><given-names>KM</given-names></name><name><surname>Janke</surname><given-names>BH</given-names></name><name><surname>Richt</surname><given-names>JA</given-names></name></person-group><article-title>Swine influenza viruses a North American perspective</article-title><source>Adv Virus Res</source><year>2008</year><volume>72</volume><fpage>127</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">19081490</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Rasheed</surname><given-names>K</given-names></name><name><surname>Akhtar</surname><given-names>M</given-names></name></person-group><article-title>Factors influencing vaccine efficacy: a general review</article-title><source>J Anim Plant Sci</source><year>2009</year><volume>19</volume><fpage>22</fpage><lpage>25</lpage></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Swayne</surname><given-names>DE</given-names></name></person-group><source>Animal influenza</source><edition>2nd ed</edition><publisher-loc>Ames, IW</publisher-loc><publisher-name>John Wiley and Sons Inc</publisher-name><year>2016</year></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahn</surname><given-names>J</given-names></name><name><surname>Hoffmann</surname><given-names>D</given-names></name><name><surname>Harder</surname><given-names>TC</given-names></name><name><surname>Beer</surname><given-names>M</given-names></name></person-group><article-title>Vaccines against influenza A viruses in poultry and swine: status and future developments</article-title><source>Vaccine</source><year>2015</year><volume>33</volume><fpage>2414</fpage><lpage>2424</lpage><pub-id pub-id-type="pmid">25835575</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spackman</surname><given-names>E</given-names></name><name><surname>Pantin-Jackwood</surname><given-names>MJ</given-names></name></person-group><article-title>Practical aspects of vaccination of poultry against avian influenza virus</article-title><source>Vet J</source><year>2014</year><volume>202</volume><fpage>408</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">25296849</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trombetta</surname><given-names>CM</given-names></name><name><surname>Perini</surname><given-names>D</given-names></name><name><surname>Mather</surname><given-names>S</given-names></name><name><surname>Temperton</surname><given-names>N</given-names></name><name><surname>Montomoli</surname><given-names>E</given-names></name></person-group><article-title>Overview of serological techniques for influenza vaccine evaluation: past, present and future</article-title><source>Vaccines (Basel)</source><year>2014</year><volume>2</volume><fpage>707</fpage><lpage>734</lpage><pub-id pub-id-type="pmid">26344888</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>AW</given-names></name><name><surname>Daly</surname><given-names>JM</given-names></name><name><surname>Lewis</surname><given-names>NS</given-names></name><name><surname>Smith</surname><given-names>DJ</given-names></name><name><surname>Wood</surname><given-names>JL</given-names></name><name><surname>Grenfell</surname><given-names>BT</given-names></name></person-group><article-title>Quantifying the impact of immune escape on transmission dynamics of influenza</article-title><source>Science</source><year>2009</year><volume>326</volume><fpage>726</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">19900931</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelwhab</surname><given-names>EM</given-names></name><name><surname>Hassan</surname><given-names>MK</given-names></name><name><surname>Abdel-Moneim</surname><given-names>AS</given-names></name><etal></etal></person-group><article-title>Introduction and enzootic of A/H5N1 in Egypt: virus evolution, pathogenicity and vaccine efficacy ten years on</article-title><source>Infect Genet Evol</source><year>2016</year><volume>40</volume><fpage>80</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">26917362</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Fusaro</surname><given-names>A</given-names></name><name><surname>Song</surname><given-names>CS</given-names></name><name><surname>Suarez</surname><given-names>DL</given-names></name><name><surname>Swayne</surname><given-names>DE</given-names></name></person-group><article-title>Poultry vaccination directed evolution of H9N2 low pathogenicity avian influenza viruses in Korea</article-title><source>Virology</source><year>2016</year><volume>488</volume><fpage>225</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">26655240</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Senne</surname><given-names>DA</given-names></name><name><surname>Suarez</surname><given-names>DL</given-names></name></person-group><article-title>Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>8372</fpage><lpage>8381</lpage><pub-id pub-id-type="pmid">15254209</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijaykrishna</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>GJ</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name><etal></etal></person-group><article-title>Long-term evolution and transmission dynamics of swine influenza A virus</article-title><source>Nature</source><year>2011</year><volume>473</volume><fpage>519</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">21614079</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harder</surname><given-names>TC</given-names></name><name><surname>Grosse Beilage</surname><given-names>E</given-names></name><name><surname>Lange</surname><given-names>E</given-names></name><etal></etal></person-group><article-title>Expanded cocirculation of stable subtypes, emerging lineages, and new sporadic reassortants of porcine influenza viruses in swine populations in Northwest Germany</article-title><source>J Virol</source><year>2013</year><volume>87</volume><fpage>10460</fpage><lpage>10476</lpage><pub-id pub-id-type="pmid">23824819</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecchinato</surname><given-names>M</given-names></name><name><surname>Catelli</surname><given-names>E</given-names></name><name><surname>Lupini</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Avian metapneumovirus (AMPV) attachment protein involvement in probable virus evolution concurrent with mass live vaccine introduction</article-title><source>Vet Microbiol</source><year>2010</year><volume>146</volume><fpage>24</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">20447777</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franzo</surname><given-names>G</given-names></name><name><surname>Tucciarone</surname><given-names>CM</given-names></name><name><surname>Cecchinato</surname><given-names>M</given-names></name><name><surname>Drigo</surname><given-names>M</given-names></name></person-group><article-title>Porcine circovirus type 2 (PCV2) evolution before and after the vaccination introduction: a large scale epidemiological study</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><elocation-id>39458</elocation-id><pub-id pub-id-type="pmid">27991573</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>DU</given-names></name><name><surname>Yoo</surname><given-names>SJ</given-names></name><name><surname>Je</surname><given-names>SH</given-names></name><name><surname>Shin</surname><given-names>JY</given-names></name><name><surname>Lyoo</surname><given-names>YS</given-names></name></person-group><article-title>Genotypic diversity of porcine circovirus type 2 (PCV2) and genotype shift to PCV2d in Korean pig population</article-title><source>Virus Res</source><year>2017</year><volume>228</volume><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">27867029</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>SJ</given-names></name><name><surname>Kwon</surname><given-names>T</given-names></name><name><surname>Kang</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Genetic evolution of classical swine fever virus under immune environments conditioned by genotype 1-based modified live virus vaccine</article-title><source>Transbound Emerg Dis</source><year>2018</year><month>1</month><day>10</day><comment>[Epub ahead of print]</comment><pub-id pub-id-type="doi">10.1111/tbed.12798</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodpothong</surname><given-names>P</given-names></name><name><surname>Auewarakul</surname><given-names>P</given-names></name></person-group><article-title>Viral evolution and transmission effectiveness</article-title><source>World J Virol</source><year>2012</year><volume>1</volume><fpage>131</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">24175217</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajao</surname><given-names>DS</given-names></name><name><surname>Loving</surname><given-names>CL</given-names></name><name><surname>Gauger</surname><given-names>PC</given-names></name><name><surname>Kitikoon</surname><given-names>P</given-names></name><name><surname>Vincent</surname><given-names>AL</given-names></name></person-group><article-title>Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>5170</fpage><lpage>5176</lpage><pub-id pub-id-type="pmid">25077416</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauger</surname><given-names>PC</given-names></name><name><surname>Vincent</surname><given-names>AL</given-names></name><name><surname>Loving</surname><given-names>CL</given-names></name><etal></etal></person-group><article-title>Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus</article-title><source>Vaccine</source><year>2011</year><volume>29</volume><fpage>2712</fpage><lpage>2719</lpage><pub-id pub-id-type="pmid">21310191</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>AL</given-names></name><name><surname>Lager</surname><given-names>KM</given-names></name><name><surname>Janke</surname><given-names>BH</given-names></name><name><surname>Gramer</surname><given-names>MR</given-names></name><name><surname>Richt</surname><given-names>JA</given-names></name></person-group><article-title>Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine</article-title><source>Vet Microbiol</source><year>2008</year><volume>126</volume><fpage>310</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">17719188</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khurana</surname><given-names>S</given-names></name><name><surname>Loving</surname><given-names>CL</given-names></name><name><surname>Manischewitz</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease</article-title><source>Sci Transl Med</source><year>2013</year><volume>5</volume><fpage>200ra114</fpage></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title>Protective efficacy of vaccination against highly pathogenic avian influenza is dramatically suppressed by early infection of chickens with reticuloendotheliosis virus</article-title><source>Avian Pathol</source><year>2009</year><volume>38</volume><fpage>31</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">19145513</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajao</surname><given-names>DS</given-names></name><name><surname>Sandbulte</surname><given-names>MR</given-names></name><name><surname>Gauger</surname><given-names>PC</given-names></name><etal></etal></person-group><article-title>Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets</article-title><source>Virology</source><year>2016</year><volume>491</volume><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">26874588</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="book"><collab>Centers for Disease Control and Prevention</collab><source>Principles of vaccination [Internet]</source><publisher-loc>Atlanta, GA</publisher-loc><publisher-name>Centers for Disease Control and Prevention</publisher-name><year>2015</year><date-in-citation content-type="access-date">cited 2017 Nov 4</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/vaccines/pubs/pinkbook/prinvac.html">https://www.cdc.gov/vaccines/pubs/pinkbook/prinvac.html</ext-link></comment></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>CT</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><etal></etal></person-group><article-title>Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><elocation-id>32973</elocation-id><pub-id pub-id-type="pmid">27596047</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savill</surname><given-names>NJ</given-names></name><name><surname>St Rose</surname><given-names>SG</given-names></name><name><surname>Keeling</surname><given-names>MJ</given-names></name><name><surname>Woolhouse</surname><given-names>ME</given-names></name></person-group><article-title>Silent spread of H5N1 in vaccinated poultry</article-title><source>Nature</source><year>2006</year><volume>442</volume><fpage>757</fpage><pub-id pub-id-type="pmid">16915278</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poetri</surname><given-names>ON</given-names></name><name><surname>Van Boven</surname><given-names>M</given-names></name><name><surname>Claassen</surname><given-names>I</given-names></name><etal></etal></person-group><article-title>Silent spread of highly pathogenic Avian Influenza H5N1 virus amongst vaccinated commercial layers</article-title><source>Res Vet Sci</source><year>2014</year><volume>97</volume><fpage>637</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">25301756</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>PF</given-names></name></person-group><article-title>Vaccine preparedness: are we ready for the next influenza pandemic?</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>2540</fpage><lpage>2543</lpage><pub-id pub-id-type="pmid">18550873</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1</article-title><source>Biochem Biophys Res Commun</source><year>2012</year><volume>421</volume><fpage>850</fpage><lpage>854</lpage><pub-id pub-id-type="pmid">22554519</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>AY</given-names></name><name><surname>Tseng</surname><given-names>YF</given-names></name><name><surname>Weng</surname><given-names>TC</given-names></name><etal></etal></person-group><article-title>Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><elocation-id>e14578</elocation-id><pub-id pub-id-type="pmid">21283675</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ping</surname><given-names>J</given-names></name><name><surname>Lopes</surname><given-names>TJ</given-names></name><name><surname>Nidom</surname><given-names>CA</given-names></name><etal></etal></person-group><article-title>Development of high-yield influenza A virus vaccine viruses</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><fpage>8148</fpage><pub-id pub-id-type="pmid">26334134</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="book"><collab>Centers for Disease Control and Prevention</collab><source>Cell-based flu vaccines [Internet]</source><publisher-loc>Atlanta, GA</publisher-loc><publisher-name>Centers for Disease Control and Prevention</publisher-name><year>2016</year><date-in-citation content-type="access-date">cited 2017 Nov 4</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/protect/vaccine/cell-based.htm">https://www.cdc.gov/flu/protect/vaccine/cell-based.htm</ext-link></comment></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JH</given-names></name><name><surname>Papania</surname><given-names>M</given-names></name><name><surname>Knaus</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><fpage>3026</fpage><lpage>3033</lpage><pub-id pub-id-type="pmid">22075083</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Mena</surname><given-names>I</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Newcastle disease virus-vectored H7 and H5 live vaccines protect chickens from challenge with H7N9 or H5N1 avian influenza viruses</article-title><source>J Virol</source><year>2015</year><volume>89</volume><fpage>7401</fpage><lpage>7408</lpage><pub-id pub-id-type="pmid">25926639</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus</article-title><source>NPJ Vaccines</source><year>2017</year><volume>2</volume><fpage>33</fpage><pub-id pub-id-type="pmid">29263888</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Jiao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title>Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges</article-title><source>Vaccine</source><year>2017</year><volume>35</volume><issue>48 Pt B</issue><fpage>6585</fpage><lpage>6590</lpage><pub-id pub-id-type="pmid">29042201</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakaya</surname><given-names>T</given-names></name><name><surname>Cros</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>MS</given-names></name><etal></etal></person-group><article-title>Recombinant Newcastle disease virus as a vaccine vector</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>11868</fpage><lpage>11873</lpage><pub-id pub-id-type="pmid">11689668</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Richt</surname><given-names>JA</given-names></name></person-group><article-title>Swine influenza vaccines: current status and future perspectives</article-title><source>Anim Health Res Rev</source><year>2010</year><volume>11</volume><fpage>81</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">20462470</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suarez</surname><given-names>DL</given-names></name><name><surname>Pantin-Jackwood</surname><given-names>MJ</given-names></name></person-group><article-title>Recombinant viral-vectored vaccines for the control of avian influenza in poultry</article-title><source>Vet Microbiol</source><year>2017</year><volume>206</volume><fpage>144</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">27916319</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsunekuni</surname><given-names>R</given-names></name><name><surname>Hikono</surname><given-names>H</given-names></name><name><surname>Tanikawa</surname><given-names>T</given-names></name><name><surname>Kurata</surname><given-names>R</given-names></name><name><surname>Nakaya</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group><article-title>Recombinant avian paramyxovirus serotypes 2, 6, and 10 as vaccine vectors for highly pathogenic avian influenza in chickens with antibodies against Newcastle disease virus</article-title><source>Avian Dis</source><year>2017</year><volume>61</volume><fpage>296</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">28957006</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>A</given-names></name><name><surname>Samal</surname><given-names>SK</given-names></name></person-group><article-title>Avian Paramyxovirus Type-3 as a Vaccine vector: identification of a genome location for high level expression of a foreign gene</article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><fpage>693</fpage><pub-id pub-id-type="pmid">28473820</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bublot</surname><given-names>M</given-names></name><name><surname>Pritchard</surname><given-names>N</given-names></name><name><surname>Swayne</surname><given-names>DE</given-names></name><etal></etal></person-group><article-title>Development and use of fowlpox vectored vaccines for avian influenza</article-title><source>Ann N Y Acad Sci</source><year>2006</year><volume>1081</volume><fpage>193</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">17135511</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard-Mazet</surname><given-names>A</given-names></name><name><surname>Goutebroze</surname><given-names>S</given-names></name><name><surname>Le Gros</surname><given-names>FX</given-names></name><name><surname>Swayne</surname><given-names>DE</given-names></name><name><surname>Bublot</surname><given-names>M</given-names></name></person-group><article-title>Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies</article-title><source>Vet Res</source><year>2014</year><volume>45</volume><fpage>107</fpage><pub-id pub-id-type="pmid">25359591</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swayne</surname><given-names>DE</given-names></name></person-group><article-title>Avian influenza vaccines and therapies for poultry</article-title><source>Comp Immunol Microbiol Infect Dis</source><year>2009</year><volume>32</volume><fpage>351</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">18442853</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iavarone</surname><given-names>C</given-names></name><name><surname>O'Hagan</surname><given-names>DT</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Delahaye</surname><given-names>NF</given-names></name><name><surname>Ulmer</surname><given-names>JB</given-names></name></person-group><article-title>Mechanism of action of mRNA-based vaccines</article-title><source>Expert Rev Vaccines</source><year>2017</year><volume>16</volume><fpage>871</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">28701102</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diken</surname><given-names>M</given-names></name><name><surname>Kreiter</surname><given-names>S</given-names></name><name><surname>Selmi</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation</article-title><source>Gene Ther</source><year>2011</year><volume>18</volume><fpage>702</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">21368901</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbalat</surname><given-names>R</given-names></name><name><surname>Ewald</surname><given-names>SE</given-names></name><name><surname>Mouchess</surname><given-names>ML</given-names></name><name><surname>Barton</surname><given-names>GM</given-names></name></person-group><article-title>Nucleic acid recognition by the innate immune system</article-title><source>Annu Rev Immunol</source><year>2011</year><volume>29</volume><fpage>185</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">21219183</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>SL</given-names></name><name><surname>Wilusz</surname><given-names>J</given-names></name></person-group><article-title>In vitro transcription of modified RNAs</article-title><source>Methods Mol Biol</source><year>2012</year><volume>941</volume><fpage>171</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">23065561</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kariko</surname><given-names>K</given-names></name><name><surname>Muramatsu</surname><given-names>H</given-names></name><name><surname>Ludwig</surname><given-names>J</given-names></name><name><surname>Weissman</surname><given-names>D</given-names></name></person-group><article-title>Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><elocation-id>e142</elocation-id><pub-id pub-id-type="pmid">21890902</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>KL</given-names></name><name><surname>Drane</surname><given-names>D</given-names></name><name><surname>Gowans</surname><given-names>EJ</given-names></name></person-group><article-title>Long-term storage of DNA-free RNA for use in vaccine studies</article-title><source>Biotechniques</source><year>2007</year><volume>43</volume><fpage>675</fpage><lpage>681</lpage><pub-id pub-id-type="pmid">18072597</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoerr</surname><given-names>I</given-names></name><name><surname>Obst</surname><given-names>R</given-names></name><name><surname>Rammensee</surname><given-names>HG</given-names></name><name><surname>Jung</surname><given-names>G</given-names></name></person-group><article-title>In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies</article-title><source>Eur J Immunol</source><year>2000</year><volume>30</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10602021</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>S</given-names></name><name><surname>Stang</surname><given-names>A</given-names></name><name><surname>Lennartz</surname><given-names>K</given-names></name><name><surname>Tenbusch</surname><given-names>M</given-names></name><name><surname>Uberla</surname><given-names>K</given-names></name></person-group><article-title>Selection of a T7 promoter mutant with enhanced in vitro activity by a novel multi-copy bead display approach for in vitro evolution</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><elocation-id>e29</elocation-id><pub-id pub-id-type="pmid">23074193</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petsch</surname><given-names>B</given-names></name><name><surname>Schnee</surname><given-names>M</given-names></name><name><surname>Vogel</surname><given-names>AB</given-names></name><etal></etal></person-group><article-title>Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection</article-title><source>Nat Biotechnol</source><year>2012</year><volume>30</volume><fpage>1210</fpage><lpage>1216</lpage><pub-id pub-id-type="pmid">23159882</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahl</surname><given-names>K</given-names></name><name><surname>Senn</surname><given-names>JJ</given-names></name><name><surname>Yuzhakov</surname><given-names>O</given-names></name><etal></etal></person-group><article-title>Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses</article-title><source>Mol Ther</source><year>2017</year><volume>25</volume><fpage>1316</fpage><lpage>1327</lpage><pub-id pub-id-type="pmid">28457665</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekiert</surname><given-names>DC</given-names></name><name><surname>Friesen</surname><given-names>RH</given-names></name><name><surname>Bhabha</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>A highly conserved neutralizing epitope on group 2 influenza A viruses</article-title><source>Science</source><year>2011</year><volume>333</volume><fpage>843</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">21737702</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiersma</surname><given-names>LC</given-names></name><name><surname>Rimmelzwaan</surname><given-names>GF</given-names></name><name><surname>de Vries</surname><given-names>RD</given-names></name></person-group><article-title>Developing universal influenza vaccines: hitting the nail, not just on the head</article-title><source>Vaccines (Basel)</source><year>2015</year><volume>3</volume><fpage>239</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">26343187</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nayak</surname><given-names>B</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>DiNapoli</surname><given-names>JM</given-names></name><etal></etal></person-group><article-title>Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity</article-title><source>J Virol</source><year>2010</year><volume>84</volume><fpage>2408</fpage><lpage>2420</lpage><pub-id pub-id-type="pmid">20032181</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>SS</given-names></name><name><surname>Webby</surname><given-names>RJ</given-names></name></person-group><article-title>Traditional and new influenza vaccines</article-title><source>Clin Microbiol Rev</source><year>2013</year><volume>26</volume><fpage>476</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">23824369</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinen</surname><given-names>PP</given-names></name><name><surname>Rijsewijk</surname><given-names>FA</given-names></name><name><surname>de Boer-Luijtze</surname><given-names>EA</given-names></name><name><surname>Bianchi</surname><given-names>AT</given-names></name></person-group><article-title>Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus</article-title><source>J Gen Virol</source><year>2002</year><volume>83</volume><fpage>1851</fpage><lpage>1859</lpage><pub-id pub-id-type="pmid">12124449</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumpey</surname><given-names>TM</given-names></name><name><surname>Alvarez</surname><given-names>R</given-names></name><name><surname>Swayne</surname><given-names>DE</given-names></name><name><surname>Suarez</surname><given-names>DL</given-names></name></person-group><article-title>Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus</article-title><source>J Clin Microbiol</source><year>2005</year><volume>43</volume><fpage>676</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">15695663</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brahmakshatriya</surname><given-names>VR</given-names></name><name><surname>Lupiani</surname><given-names>B</given-names></name><name><surname>Reddy</surname><given-names>SM</given-names></name></person-group><article-title>Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>2388</fpage><lpage>2396</lpage><pub-id pub-id-type="pmid">20064474</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohrs</surname><given-names>S</given-names></name><name><surname>Kalthoff</surname><given-names>D</given-names></name><name><surname>Beer</surname><given-names>M</given-names></name></person-group><article-title>A model for early onset of protection against lethal challenge with highly pathogenic H5N1 influenza virus</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>2631</fpage><lpage>2636</lpage><pub-id pub-id-type="pmid">24674664</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Schematic representation of the related factors for successful vaccination.</title></caption><graphic xlink:href="cevr-7-1-g001"></graphic></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Definitions and examples of disease outbreak costs</title></caption><alternatives><graphic xlink:href="cevr-7-1-i001"></graphic><table frame="hsides" rules="rows"><col width="12.04%" span="1"></col><col width="15.71%" span="1"></col><col width="36.13%" span="1"></col><col width="36.13%" span="1"></col><thead><tr><th valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)"></th><th valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)"></th><th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Definition</th><th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Example</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="10" colspan="1">Direct costs</td><td valign="top" align="left" rowspan="3" colspan="1">Direct losses</td><td valign="top" align="left" rowspan="3" colspan="1">Direct losses originate from either the disease itself or sanitary control measures (stamping-out policies). The costs include culling and disposal costs as well as the value of culled animals.</td><td valign="top" align="left" rowspan="1" colspan="1">Value of culled animals (including pre-emptive and welfare slaughter)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Culling</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disposal</td></tr><tr><td valign="top" align="left" rowspan="5" colspan="1">Control costs</td><td valign="top" align="left" rowspan="5" colspan="1">Control costs are incurred from expenses for equipment, facilities, disinfectants, protective clothing, and quarantine facility staffs during and after the disease outbreaks. The costs may also involve (ring) vaccination when it is applied.</td><td valign="top" align="left" rowspan="1" colspan="1">Cleansing and disinfection, etc.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Veterinary inputs</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Administration of control measures</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Serology</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">(Ring) vaccination/buffer zone</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Other direct production losses</td><td valign="top" align="left" rowspan="2" colspan="1">Economic losses on farm as a result of the fall in stock, movement restrictions, and the loss in animal value.</td><td valign="top" align="left" rowspan="1" colspan="1">Business interruption losses directly caused by veterinary movement restrictions</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Partial loss of animal value (e.g., through vaccination etc.)</td></tr><tr><td valign="top" align="left" rowspan="4" colspan="1" style="background-color:rgb(255,240,220)">Indirect costs</td><td valign="top" align="left" rowspan="3" colspan="1" style="background-color:rgb(255,240,220)">Ripple effects</td><td valign="top" align="left" rowspan="3" colspan="1" style="background-color:rgb(255,240,220)">These are cascading effects on upstream and downstream activities along the value chain of the livestock following the disease outbreaks. The value chain consists of breeding, feed production, input supply production, collection and trade (of eggs or live birds), slaughter, processing, final sale, and consumption.</td><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Price effects regarding livestock/livestock products</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Loss of access/opportunity to access, regional and international markets</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Impact on inputs (feed, breeding chicks, veterinary medicines)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Spill-over effects</td><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Spill-over effects by disease outbreaks can occur in a context seemingly unrelated with agriculture, such as tourism and services. These two sectors are the most likely to be affected and the consequential economic impacts can be severe according to their contributions to national economy.</td><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Drop in demand in the services sector (tourism, public transport, retail trade, hospitality, and food services)</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>Modified from the World Organisation for Animal Health (2007), with permission of World Organisation for Animal Health [<xref rid="B40" ref-type="bibr">40</xref>].</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Influenza A viruses (IAVs) in swine by region originated from human seasonal IAVs with isolation year of the most closely related genetic ancestor<sup>a)</sup></title></caption><alternatives><graphic xlink:href="cevr-7-1-i002"></graphic><table frame="hsides" rules="rows"><col width="20%" span="1"></col><col width="40%" span="1"></col><col width="20%" span="1"></col><col width="20%" span="1"></col><thead><tr><th valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Subtype</th><th valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Region or country</th><th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">HA</th><th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">NA</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="2" colspan="1">H1N1</td><td valign="top" align="left" rowspan="1" colspan="1">North America</td><td valign="top" align="center" rowspan="1" colspan="1">2003</td><td valign="top" align="center" rowspan="1" colspan="1">2003</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Argentina</td><td valign="top" align="center" rowspan="1" colspan="1">2003</td><td valign="top" align="center" rowspan="1" colspan="1">2003</td></tr><tr><td valign="top" align="left" rowspan="4" colspan="1" style="background-color:rgb(255,240,220)">H1N2</td><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">North America</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">2003</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">2003</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Argentina</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">2003</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">2003</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Brazil</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">2002</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">1997</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">Europe</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">1980</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(255,240,220)">1973</td></tr><tr><td valign="top" align="left" rowspan="13" colspan="1">H3N2</td><td valign="top" align="left" rowspan="2" colspan="1">North America</td><td valign="top" align="center" rowspan="1" colspan="1">1996</td><td valign="top" align="center" rowspan="1" colspan="1">1996</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"></td><td valign="top" align="center" rowspan="1" colspan="1">2003</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Argentina</td><td valign="top" align="center" rowspan="1" colspan="1">2001</td><td valign="top" align="center" rowspan="1" colspan="1">2002</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Europe</td><td valign="top" align="center" rowspan="1" colspan="1">1973</td><td valign="top" align="center" rowspan="1" colspan="1">1973</td></tr><tr><td valign="top" align="left" rowspan="4" colspan="1">China</td><td valign="top" align="center" rowspan="1" colspan="1">1968</td><td valign="top" align="center" rowspan="1" colspan="1">1968</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1">1973</td><td valign="top" align="center" rowspan="1" colspan="1">1973</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1">1997</td><td valign="top" align="center" rowspan="1" colspan="1">1997</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1">2004</td><td valign="top" align="center" rowspan="1" colspan="1">2004</td></tr><tr><td valign="top" align="left" rowspan="2" colspan="1">Thailand</td><td valign="top" align="center" rowspan="1" colspan="1">1976</td><td valign="top" align="center" rowspan="1" colspan="1">1976</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1">1997</td><td valign="top" align="center" rowspan="1" colspan="1">1997</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Japan</td><td valign="top" align="center" rowspan="1" colspan="1">1968</td><td valign="top" align="center" rowspan="1" colspan="1">1968</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vietnam</td><td valign="top" align="center" rowspan="1" colspan="1">2004</td><td valign="top" align="center" rowspan="1" colspan="1">2004</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">South Korea</td><td valign="top" align="center" rowspan="1" colspan="1">1995</td><td valign="top" align="center" rowspan="1" colspan="1">1995</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>Modified from Vincent et al. Zoonoses Public Health 2014;61:4-17, with permission of John Wiley & Sons [<xref rid="B9" ref-type="bibr">9</xref>].</p><p>HA, hemagglutinin; NA, neuraminidase.</p><p><sup>a)</sup>The information of H1N1pdm09 transmitted from human to pig was excluded.</p></fn></table-wrap-foot></table-wrap></floats-group></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D16 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000D16 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:5795040
|texte= Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:29399575" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |